TW508247B - Cosmetic or dermatological topical composition - Google Patents
Cosmetic or dermatological topical composition Download PDFInfo
- Publication number
- TW508247B TW508247B TW087104724A TW87104724A TW508247B TW 508247 B TW508247 B TW 508247B TW 087104724 A TW087104724 A TW 087104724A TW 87104724 A TW87104724 A TW 87104724A TW 508247 B TW508247 B TW 508247B
- Authority
- TW
- Taiwan
- Prior art keywords
- acid
- oil
- poe
- ingredients
- amino acid
- Prior art date
Links
- 239000002537 cosmetic Substances 0.000 title claims abstract description 11
- 230000000699 topical effect Effects 0.000 title claims abstract description 4
- 239000000203 mixture Substances 0.000 title claims description 42
- 230000015556 catabolic process Effects 0.000 claims abstract description 6
- 238000006731 degradation reaction Methods 0.000 claims abstract description 6
- 150000001370 alpha-amino acid derivatives Chemical class 0.000 claims abstract 6
- -1 N-dodecylglycine Potassium amine salt Chemical class 0.000 claims description 72
- 125000000217 alkyl group Chemical group 0.000 claims description 33
- 150000001875 compounds Chemical class 0.000 claims description 20
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 claims description 12
- QNAYBMKLOCPYGJ-UHFFFAOYSA-N Alanine Chemical compound CC([NH3+])C([O-])=O QNAYBMKLOCPYGJ-UHFFFAOYSA-N 0.000 claims description 11
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 claims description 11
- 150000003839 salts Chemical class 0.000 claims description 9
- MTCFGRXMJLQNBG-UHFFFAOYSA-N serine Chemical compound OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 claims description 9
- 125000003983 fluorenyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3CC12)* 0.000 claims description 8
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 8
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 8
- 125000001424 substituent group Chemical group 0.000 claims description 8
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 6
- 150000001733 carboxylic acid esters Chemical class 0.000 claims description 6
- 229960001153 serine Drugs 0.000 claims description 6
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 claims description 5
- 229960003767 alanine Drugs 0.000 claims description 5
- 239000003085 diluting agent Substances 0.000 claims description 4
- 229950010030 dl-alanine Drugs 0.000 claims description 4
- 125000003258 trimethylene group Chemical group [H]C([H])([*:2])C([H])([H])C([H])([H])[*:1] 0.000 claims description 4
- 239000004471 Glycine Substances 0.000 claims description 3
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 claims description 3
- QNAYBMKLOCPYGJ-UWTATZPHSA-N L-Alanine Natural products C[C@@H](N)C(O)=O QNAYBMKLOCPYGJ-UWTATZPHSA-N 0.000 claims description 3
- 239000002671 adjuvant Substances 0.000 claims description 3
- PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 claims description 3
- 229960002591 hydroxyproline Drugs 0.000 claims description 3
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 claims description 2
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 claims description 2
- 229960002429 proline Drugs 0.000 claims description 2
- 235000008206 alpha-amino acids Nutrition 0.000 claims 2
- 229960002449 glycine Drugs 0.000 claims 1
- 238000002360 preparation method Methods 0.000 abstract description 45
- 210000003491 skin Anatomy 0.000 abstract description 27
- 210000000434 stratum corneum Anatomy 0.000 abstract description 24
- 239000004480 active ingredient Substances 0.000 abstract description 6
- 230000002708 enhancing effect Effects 0.000 abstract description 3
- 206010040844 Skin exfoliation Diseases 0.000 abstract 1
- 230000035618 desquamation Effects 0.000 abstract 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 69
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 65
- 239000004615 ingredient Substances 0.000 description 48
- 239000000284 extract Substances 0.000 description 41
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 40
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 35
- 235000014113 dietary fatty acids Nutrition 0.000 description 26
- 229930195729 fatty acid Natural products 0.000 description 26
- 239000000194 fatty acid Substances 0.000 description 26
- 238000011049 filling Methods 0.000 description 26
- 239000003921 oil Substances 0.000 description 26
- 235000019198 oils Nutrition 0.000 description 25
- 235000011187 glycerol Nutrition 0.000 description 24
- 239000000243 solution Substances 0.000 description 23
- 239000008346 aqueous phase Substances 0.000 description 19
- 235000019437 butane-1,3-diol Nutrition 0.000 description 18
- 239000002253 acid Substances 0.000 description 15
- 230000000694 effects Effects 0.000 description 15
- 238000009472 formulation Methods 0.000 description 14
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 13
- 150000004665 fatty acids Chemical class 0.000 description 13
- 239000001993 wax Substances 0.000 description 13
- 230000002079 cooperative effect Effects 0.000 description 12
- 229940055577 oleyl alcohol Drugs 0.000 description 12
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 12
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 11
- 239000004359 castor oil Substances 0.000 description 10
- 235000019438 castor oil Nutrition 0.000 description 10
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 10
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 10
- 239000011734 sodium Substances 0.000 description 10
- 229910052708 sodium Inorganic materials 0.000 description 10
- 235000015424 sodium Nutrition 0.000 description 10
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 9
- 239000003795 chemical substances by application Substances 0.000 description 9
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 9
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 9
- 239000012071 phase Substances 0.000 description 9
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 9
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical class OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 8
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 8
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 8
- DNIAPMSPPWPWGF-UHFFFAOYSA-N monopropylene glycol Natural products CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 8
- 229910052757 nitrogen Inorganic materials 0.000 description 8
- 239000000600 sorbitol Substances 0.000 description 8
- URDCARMUOSMFFI-UHFFFAOYSA-N 2-[2-[bis(carboxymethyl)amino]ethyl-(2-hydroxyethyl)amino]acetic acid Chemical compound OCCN(CC(O)=O)CCN(CC(O)=O)CC(O)=O URDCARMUOSMFFI-UHFFFAOYSA-N 0.000 description 7
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 7
- 239000007864 aqueous solution Substances 0.000 description 7
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 7
- 235000019388 lanolin Nutrition 0.000 description 7
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 7
- 229920000642 polymer Polymers 0.000 description 7
- 239000004094 surface-active agent Substances 0.000 description 7
- CMCBDXRRFKYBDG-UHFFFAOYSA-N 1-dodecoxydodecane Chemical compound CCCCCCCCCCCCOCCCCCCCCCCCC CMCBDXRRFKYBDG-UHFFFAOYSA-N 0.000 description 6
- 239000004166 Lanolin Substances 0.000 description 6
- 235000021355 Stearic acid Nutrition 0.000 description 6
- 239000006096 absorbing agent Substances 0.000 description 6
- 150000001298 alcohols Chemical class 0.000 description 6
- 229940024606 amino acid Drugs 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 239000003925 fat Substances 0.000 description 6
- 235000019197 fats Nutrition 0.000 description 6
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 6
- 229940039717 lanolin Drugs 0.000 description 6
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 6
- 239000008117 stearic acid Substances 0.000 description 6
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 6
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 5
- HIXDQWDOVZUNNA-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-5-hydroxy-7-methoxychromen-4-one Chemical compound C=1C(OC)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(OC)C(OC)=C1 HIXDQWDOVZUNNA-UHFFFAOYSA-N 0.000 description 5
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 5
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 5
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 5
- 239000005642 Oleic acid Substances 0.000 description 5
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 5
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 5
- 230000001086 cytosolic effect Effects 0.000 description 5
- LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 description 5
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 5
- 230000003020 moisturizing effect Effects 0.000 description 5
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 5
- NTTOTNSKUYCDAV-UHFFFAOYSA-N potassium hydride Chemical compound [KH] NTTOTNSKUYCDAV-UHFFFAOYSA-N 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- ZORQXIQZAOLNGE-UHFFFAOYSA-N 1,1-difluorocyclohexane Chemical compound FC1(F)CCCCC1 ZORQXIQZAOLNGE-UHFFFAOYSA-N 0.000 description 4
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 4
- HMFKFHLTUCJZJO-UHFFFAOYSA-N 2-{2-[3,4-bis(2-hydroxyethoxy)oxolan-2-yl]-2-(2-hydroxyethoxy)ethoxy}ethyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCCOCC(OCCO)C1OCC(OCCO)C1OCCO HMFKFHLTUCJZJO-UHFFFAOYSA-N 0.000 description 4
- XZIIFPSPUDAGJM-UHFFFAOYSA-N 6-chloro-2-n,2-n-diethylpyrimidine-2,4-diamine Chemical compound CCN(CC)C1=NC(N)=CC(Cl)=N1 XZIIFPSPUDAGJM-UHFFFAOYSA-N 0.000 description 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 239000004909 Moisturizer Substances 0.000 description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 4
- 229920001214 Polysorbate 60 Polymers 0.000 description 4
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical class OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 4
- 229960000541 cetyl alcohol Drugs 0.000 description 4
- 235000019864 coconut oil Nutrition 0.000 description 4
- 239000003240 coconut oil Substances 0.000 description 4
- UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 description 4
- 239000000839 emulsion Substances 0.000 description 4
- 238000011156 evaluation Methods 0.000 description 4
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 230000001333 moisturizer Effects 0.000 description 4
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 4
- 235000021313 oleic acid Nutrition 0.000 description 4
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 4
- 229920001296 polysiloxane Polymers 0.000 description 4
- 235000018102 proteins Nutrition 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 4
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 4
- 229940035044 sorbitan monolaurate Drugs 0.000 description 4
- 229940032094 squalane Drugs 0.000 description 4
- 229960001295 tocopherol Drugs 0.000 description 4
- 239000011732 tocopherol Substances 0.000 description 4
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 3
- FFJCNSLCJOQHKM-CLFAGFIQSA-N (z)-1-[(z)-octadec-9-enoxy]octadec-9-ene Chemical compound CCCCCCCC\C=C/CCCCCCCCOCCCCCCCC\C=C/CCCCCCCC FFJCNSLCJOQHKM-CLFAGFIQSA-N 0.000 description 3
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical class CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 3
- 102000011799 Desmoglein Human genes 0.000 description 3
- 108050002238 Desmoglein Proteins 0.000 description 3
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 3
- 206010013786 Dry skin Diseases 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- 239000005639 Lauric acid Substances 0.000 description 3
- 235000019482 Palm oil Nutrition 0.000 description 3
- 239000002202 Polyethylene glycol Substances 0.000 description 3
- 241000220324 Pyrus Species 0.000 description 3
- 235000014443 Pyrus communis Nutrition 0.000 description 3
- 229920002472 Starch Polymers 0.000 description 3
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 3
- XOAAWQZATWQOTB-UHFFFAOYSA-N Taurine Natural products NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 3
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 3
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 3
- 235000001014 amino acid Nutrition 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 230000003796 beauty Effects 0.000 description 3
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid group Chemical group C(C1=CC=CC=C1)(=O)O WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 3
- 229960003237 betaine Drugs 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 239000010495 camellia oil Substances 0.000 description 3
- 239000000969 carrier Substances 0.000 description 3
- 229920002678 cellulose Polymers 0.000 description 3
- 239000001913 cellulose Substances 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 3
- GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 3
- 230000035613 defoliation Effects 0.000 description 3
- 238000004821 distillation Methods 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 230000037336 dry skin Effects 0.000 description 3
- 229940088598 enzyme Drugs 0.000 description 3
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 3
- 239000007789 gas Substances 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 239000004310 lactic acid Substances 0.000 description 3
- 235000014655 lactic acid Nutrition 0.000 description 3
- 150000002632 lipids Chemical class 0.000 description 3
- 239000006210 lotion Substances 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 125000004433 nitrogen atom Chemical group N* 0.000 description 3
- 239000002540 palm oil Substances 0.000 description 3
- 229940056211 paraffin Drugs 0.000 description 3
- 239000012188 paraffin wax Substances 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 229920000573 polyethylene Polymers 0.000 description 3
- 229920001223 polyethylene glycol Polymers 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 239000001593 sorbitan monooleate Substances 0.000 description 3
- 229940035049 sorbitan monooleate Drugs 0.000 description 3
- 239000008107 starch Substances 0.000 description 3
- 235000019698 starch Nutrition 0.000 description 3
- 239000011975 tartaric acid Substances 0.000 description 3
- 235000002906 tartaric acid Nutrition 0.000 description 3
- 235000010384 tocopherol Nutrition 0.000 description 3
- 229930003799 tocopherol Natural products 0.000 description 3
- 229940099259 vaseline Drugs 0.000 description 3
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 description 2
- AJDLZUBEKJQNMJ-DKWTVANSSA-N (2s)-2-amino-3-hydroxypropanoic acid;ethanol Chemical compound CCO.OC[C@H](N)C(O)=O AJDLZUBEKJQNMJ-DKWTVANSSA-N 0.000 description 2
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 description 2
- KBPLFHHGFOOTCA-UHFFFAOYSA-N 1-Octanol Chemical compound CCCCCCCCO KBPLFHHGFOOTCA-UHFFFAOYSA-N 0.000 description 2
- ULQISTXYYBZJSJ-UHFFFAOYSA-N 12-hydroxyoctadecanoic acid Chemical compound CCCCCCC(O)CCCCCCCCCCC(O)=O ULQISTXYYBZJSJ-UHFFFAOYSA-N 0.000 description 2
- WNWHHMBRJJOGFJ-UHFFFAOYSA-N 16-methylheptadecan-1-ol Chemical compound CC(C)CCCCCCCCCCCCCCCO WNWHHMBRJJOGFJ-UHFFFAOYSA-N 0.000 description 2
- WXTMDXOMEHJXQO-UHFFFAOYSA-N 2,5-dihydroxybenzoic acid Chemical compound OC(=O)C1=CC(O)=CC=C1O WXTMDXOMEHJXQO-UHFFFAOYSA-N 0.000 description 2
- WRMNZCZEMHIOCP-UHFFFAOYSA-N 2-phenylethanol Chemical compound OCCC1=CC=CC=C1 WRMNZCZEMHIOCP-UHFFFAOYSA-N 0.000 description 2
- YQUVCSBJEUQKSH-UHFFFAOYSA-N 3,4-dihydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(O)C(O)=C1 YQUVCSBJEUQKSH-UHFFFAOYSA-N 0.000 description 2
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 235000021357 Behenic acid Nutrition 0.000 description 2
- 239000005711 Benzoic acid Substances 0.000 description 2
- 235000016068 Berberis vulgaris Nutrition 0.000 description 2
- 241000335053 Beta vulgaris Species 0.000 description 2
- QFOHBWFCKVYLES-UHFFFAOYSA-N Butylparaben Chemical compound CCCCOC(=O)C1=CC=C(O)C=C1 QFOHBWFCKVYLES-UHFFFAOYSA-N 0.000 description 2
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 2
- 241000282465 Canis Species 0.000 description 2
- 239000004215 Carbon black (E152) Substances 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
- 108090000317 Chymotrypsin Proteins 0.000 description 2
- 229920000742 Cotton Polymers 0.000 description 2
- 241000195493 Cryptophyta Species 0.000 description 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- 239000001263 FEMA 3042 Substances 0.000 description 2
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 2
- FFDGPVCHZBVARC-UHFFFAOYSA-N N,N-dimethylglycine Chemical compound CN(C)CC(O)=O FFDGPVCHZBVARC-UHFFFAOYSA-N 0.000 description 2
- 240000002853 Nelumbo nucifera Species 0.000 description 2
- 235000006508 Nelumbo nucifera Nutrition 0.000 description 2
- 235000006510 Nelumbo pentapetala Nutrition 0.000 description 2
- 240000007594 Oryza sativa Species 0.000 description 2
- 235000007164 Oryza sativa Nutrition 0.000 description 2
- 235000021314 Palmitic acid Nutrition 0.000 description 2
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Natural products OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 description 2
- 108091005804 Peptidases Proteins 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 2
- 239000004365 Protease Substances 0.000 description 2
- VYGQUTWHTHXGQB-FFHKNEKCSA-N Retinol Palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-FFHKNEKCSA-N 0.000 description 2
- 235000019774 Rice Bran oil Nutrition 0.000 description 2
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 2
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 2
- 229930182558 Sterol Natural products 0.000 description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 240000008042 Zea mays Species 0.000 description 2
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 2
- 229910052783 alkali metal Inorganic materials 0.000 description 2
- 150000003973 alkyl amines Chemical class 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 2
- 125000003277 amino group Chemical group 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 2
- 235000010323 ascorbic acid Nutrition 0.000 description 2
- 229960005070 ascorbic acid Drugs 0.000 description 2
- 239000011668 ascorbic acid Substances 0.000 description 2
- 235000013871 bee wax Nutrition 0.000 description 2
- 235000015278 beef Nutrition 0.000 description 2
- 239000012166 beeswax Substances 0.000 description 2
- 229940116226 behenic acid Drugs 0.000 description 2
- ISAOCJYIOMOJEB-UHFFFAOYSA-N benzoin Chemical compound C=1C=CC=CC=1C(O)C(=O)C1=CC=CC=C1 ISAOCJYIOMOJEB-UHFFFAOYSA-N 0.000 description 2
- KVYGGMBOZFWZBQ-UHFFFAOYSA-N benzyl nicotinate Chemical compound C=1C=CN=CC=1C(=O)OCC1=CC=CC=C1 KVYGGMBOZFWZBQ-UHFFFAOYSA-N 0.000 description 2
- 239000004305 biphenyl Substances 0.000 description 2
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 2
- 239000005018 casein Substances 0.000 description 2
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 2
- 235000021240 caseins Nutrition 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 239000002738 chelating agent Substances 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 229960002376 chymotrypsin Drugs 0.000 description 2
- 239000007859 condensation product Substances 0.000 description 2
- 235000005822 corn Nutrition 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- MWKFXSUHUHTGQN-UHFFFAOYSA-N decan-1-ol Chemical compound CCCCCCCCCCO MWKFXSUHUHTGQN-UHFFFAOYSA-N 0.000 description 2
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 2
- DQMDRSZNNUHESM-UHFFFAOYSA-N disulfanium;butanedioate Chemical compound [SH3+].[SH3+].[O-]C(=O)CCC([O-])=O DQMDRSZNNUHESM-UHFFFAOYSA-N 0.000 description 2
- YRIUSKIDOIARQF-UHFFFAOYSA-N dodecyl benzenesulfonate Chemical compound CCCCCCCCCCCCOS(=O)(=O)C1=CC=CC=C1 YRIUSKIDOIARQF-UHFFFAOYSA-N 0.000 description 2
- 229940071161 dodecylbenzenesulfonate Drugs 0.000 description 2
- 239000010776 emu oil Substances 0.000 description 2
- 238000004945 emulsification Methods 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 description 2
- 239000010685 fatty oil Substances 0.000 description 2
- 239000006260 foam Substances 0.000 description 2
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 2
- LRBQNJMCXXYXIU-QWKBTXIPSA-N gallotannic acid Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@H]2[C@@H]([C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-QWKBTXIPSA-N 0.000 description 2
- YQEMORVAKMFKLG-UHFFFAOYSA-N glycerine monostearate Natural products CCCCCCCCCCCCCCCCCC(=O)OC(CO)CO YQEMORVAKMFKLG-UHFFFAOYSA-N 0.000 description 2
- SVUQHVRAGMNPLW-UHFFFAOYSA-N glycerol monostearate Natural products CCCCCCCCCCCCCCCCC(=O)OCC(O)CO SVUQHVRAGMNPLW-UHFFFAOYSA-N 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 2
- 229930195733 hydrocarbon Natural products 0.000 description 2
- 150000002430 hydrocarbons Chemical class 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- VKOBVWXKNCXXDE-UHFFFAOYSA-N icosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCC(O)=O VKOBVWXKNCXXDE-UHFFFAOYSA-N 0.000 description 2
- 210000002510 keratinocyte Anatomy 0.000 description 2
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 2
- 239000011976 maleic acid Substances 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 229920000609 methyl cellulose Polymers 0.000 description 2
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 description 2
- 235000010981 methylcellulose Nutrition 0.000 description 2
- 239000001923 methylcellulose Substances 0.000 description 2
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 2
- 239000002736 nonionic surfactant Substances 0.000 description 2
- WWZKQHOCKIZLMA-UHFFFAOYSA-M octanoate Chemical class CCCCCCCC([O-])=O WWZKQHOCKIZLMA-UHFFFAOYSA-M 0.000 description 2
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 2
- 235000014593 oils and fats Nutrition 0.000 description 2
- 229940049964 oleate Drugs 0.000 description 2
- PXQPEWDEAKTCGB-UHFFFAOYSA-N orotic acid Chemical compound OC(=O)C1=CC(=O)NC(=O)N1 PXQPEWDEAKTCGB-UHFFFAOYSA-N 0.000 description 2
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 2
- 239000002304 perfume Substances 0.000 description 2
- ZQBAKBUEJOMQEX-UHFFFAOYSA-N phenyl salicylate Chemical compound OC1=CC=CC=C1C(=O)OC1=CC=CC=C1 ZQBAKBUEJOMQEX-UHFFFAOYSA-N 0.000 description 2
- 229940093430 polyethylene glycol 1500 Drugs 0.000 description 2
- 229920001451 polypropylene glycol Polymers 0.000 description 2
- 229910000105 potassium hydride Inorganic materials 0.000 description 2
- 235000008160 pyridoxine Nutrition 0.000 description 2
- 239000011677 pyridoxine Substances 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 235000009566 rice Nutrition 0.000 description 2
- 239000008165 rice bran oil Substances 0.000 description 2
- 229960004889 salicylic acid Drugs 0.000 description 2
- CXMXRPHRNRROMY-UHFFFAOYSA-N sebacic acid Chemical compound OC(=O)CCCCCCCCC(O)=O CXMXRPHRNRROMY-UHFFFAOYSA-N 0.000 description 2
- 239000000344 soap Substances 0.000 description 2
- 239000001488 sodium phosphate Substances 0.000 description 2
- 229910000162 sodium phosphate Inorganic materials 0.000 description 2
- DAJSVUQLFFJUSX-UHFFFAOYSA-M sodium;dodecane-1-sulfonate Chemical compound [Na+].CCCCCCCCCCCCS([O-])(=O)=O DAJSVUQLFFJUSX-UHFFFAOYSA-M 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 235000011069 sorbitan monooleate Nutrition 0.000 description 2
- 235000011076 sorbitan monostearate Nutrition 0.000 description 2
- 239000001587 sorbitan monostearate Substances 0.000 description 2
- 229940035048 sorbitan monostearate Drugs 0.000 description 2
- 235000013599 spices Nutrition 0.000 description 2
- 150000003432 sterols Chemical class 0.000 description 2
- 235000003702 sterols Nutrition 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 229940033123 tannic acid Drugs 0.000 description 2
- 235000015523 tannic acid Nutrition 0.000 description 2
- 229920002258 tannic acid Polymers 0.000 description 2
- 229940104261 taurate Drugs 0.000 description 2
- HLZKNKRTKFSKGZ-UHFFFAOYSA-N tetradecan-1-ol Chemical compound CCCCCCCCCCCCCCO HLZKNKRTKFSKGZ-UHFFFAOYSA-N 0.000 description 2
- TUNFSRHWOTWDNC-UHFFFAOYSA-N tetradecanoic acid Chemical class CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 description 2
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 2
- 125000003944 tolyl group Chemical group 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- QAIPRVGONGVQAS-DUXPYHPUSA-N trans-caffeic acid Chemical compound OC(=O)\C=C\C1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-DUXPYHPUSA-N 0.000 description 2
- ARCGXLSVLAOJQL-UHFFFAOYSA-N trimellitic acid Chemical compound OC(=O)C1=CC=C(C(O)=O)C(C(O)=O)=C1 ARCGXLSVLAOJQL-UHFFFAOYSA-N 0.000 description 2
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 2
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 2
- ZDPHROOEEOARMN-UHFFFAOYSA-N undecanoic acid Chemical compound CCCCCCCCCCC(O)=O ZDPHROOEEOARMN-UHFFFAOYSA-N 0.000 description 2
- 230000002485 urinary effect Effects 0.000 description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 description 2
- 239000004034 viscosity adjusting agent Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940011671 vitamin b6 Drugs 0.000 description 2
- NOOLISFMXDJSKH-KXUCPTDWSA-N (-)-Menthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O NOOLISFMXDJSKH-KXUCPTDWSA-N 0.000 description 1
- BJBUEDPLEOHJGE-UHFFFAOYSA-N (2R,3S)-3-Hydroxy-2-pyrolidinecarboxylic acid Natural products OC1CCNC1C(O)=O BJBUEDPLEOHJGE-UHFFFAOYSA-N 0.000 description 1
- DVSZKTAMJJTWFG-SKCDLICFSA-N (2e,4e,6e,8e,10e,12e)-docosa-2,4,6,8,10,12-hexaenoic acid Chemical compound CCCCCCCCC\C=C\C=C\C=C\C=C\C=C\C=C\C(O)=O DVSZKTAMJJTWFG-SKCDLICFSA-N 0.000 description 1
- URZGHMFEWPZZTF-VAGRMJETSA-N (2s)-2-aminobutanedioic acid;2-[bis(2-hydroxyethyl)amino]ethanol Chemical compound OC(=O)[C@@H](N)CC(O)=O.OCCN(CCO)CCO.OCCN(CCO)CCO URZGHMFEWPZZTF-VAGRMJETSA-N 0.000 description 1
- AAWZDTNXLSGCEK-LNVDRNJUSA-N (3r,5r)-1,3,4,5-tetrahydroxycyclohexane-1-carboxylic acid Chemical compound O[C@@H]1CC(O)(C(O)=O)C[C@@H](O)C1O AAWZDTNXLSGCEK-LNVDRNJUSA-N 0.000 description 1
- NPWMTBZSRRLQNJ-VKHMYHEASA-N (3s)-3-aminopiperidine-2,6-dione Chemical compound N[C@H]1CCC(=O)NC1=O NPWMTBZSRRLQNJ-VKHMYHEASA-N 0.000 description 1
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- ACEAELOMUCBPJP-UHFFFAOYSA-N (E)-3,4,5-trihydroxycinnamic acid Natural products OC(=O)C=CC1=CC(O)=C(O)C(O)=C1 ACEAELOMUCBPJP-UHFFFAOYSA-N 0.000 description 1
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- YXHVCZZLWZYHSA-UHFFFAOYSA-N (Z)-6-[8-pentadecenyl]salicylic acid Natural products CCCCCCC=CCCCCCCCC1=CC=CC(O)=C1C(O)=O YXHVCZZLWZYHSA-UHFFFAOYSA-N 0.000 description 1
- PSBDWGZCVUAZQS-UHFFFAOYSA-N (dimethylsulfonio)acetate Chemical compound C[S+](C)CC([O-])=O PSBDWGZCVUAZQS-UHFFFAOYSA-N 0.000 description 1
- RBNPOMFGQQGHHO-UHFFFAOYSA-N -2,3-Dihydroxypropanoic acid Natural products OCC(O)C(O)=O RBNPOMFGQQGHHO-UHFFFAOYSA-N 0.000 description 1
- VGLVSMNWXDHPHX-UHFFFAOYSA-N 1,1,2,2,3,3,4,4,5,5-decamethylpentasilolane Chemical compound C[Si]1(C)[Si](C)(C)[Si](C)(C)[Si](C)(C)[Si]1(C)C VGLVSMNWXDHPHX-UHFFFAOYSA-N 0.000 description 1
- DXMNMEWATKSWOT-UHFFFAOYSA-N 1-[2,3-di(nonyl)phenoxy]-2,3-di(nonyl)benzene Chemical compound CCCCCCCCCC1=CC=CC(OC=2C(=C(CCCCCCCCC)C=CC=2)CCCCCCCCC)=C1CCCCCCCCC DXMNMEWATKSWOT-UHFFFAOYSA-N 0.000 description 1
- GYSCBCSGKXNZRH-UHFFFAOYSA-N 1-benzothiophene-2-carboxamide Chemical compound C1=CC=C2SC(C(=O)N)=CC2=C1 GYSCBCSGKXNZRH-UHFFFAOYSA-N 0.000 description 1
- DURPTKYDGMDSBL-UHFFFAOYSA-N 1-butoxybutane Chemical compound CCCCOCCCC DURPTKYDGMDSBL-UHFFFAOYSA-N 0.000 description 1
- ZXNAIPHYBVMMPY-KTKRTIGZSA-N 1-erucoylglycerol Chemical compound CCCCCCCC\C=C/CCCCCCCCCCCC(=O)OCC(O)CO ZXNAIPHYBVMMPY-KTKRTIGZSA-N 0.000 description 1
- FDCJDKXCCYFOCV-UHFFFAOYSA-N 1-hexadecoxyhexadecane Chemical compound CCCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCC FDCJDKXCCYFOCV-UHFFFAOYSA-N 0.000 description 1
- 125000004066 1-hydroxyethyl group Chemical group [H]OC([H])([*])C([H])([H])[H] 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- HBXWUCXDUUJDRB-UHFFFAOYSA-N 1-octadecoxyoctadecane Chemical compound CCCCCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCCCC HBXWUCXDUUJDRB-UHFFFAOYSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- 229940114072 12-hydroxystearic acid Drugs 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- ZONJATNKKGGVSU-UHFFFAOYSA-M 14-methylpentadecanoate Chemical compound CC(C)CCCCCCCCCCCCC([O-])=O ZONJATNKKGGVSU-UHFFFAOYSA-M 0.000 description 1
- LGEZTMRIZWCDLW-UHFFFAOYSA-N 14-methylpentadecyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCC(C)C LGEZTMRIZWCDLW-UHFFFAOYSA-N 0.000 description 1
- OCWPEQFHKVUBTB-HVDRVSQOSA-N 16-methylheptadecanoic acid;(2s)-5-oxopyrrolidine-2-carboxylic acid Chemical compound OC(=O)[C@@H]1CCC(=O)N1.CC(C)CCCCCCCCCCCCCCC(O)=O OCWPEQFHKVUBTB-HVDRVSQOSA-N 0.000 description 1
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 description 1
- SPSPIUSUWPLVKD-UHFFFAOYSA-N 2,3-dibutyl-6-methylphenol Chemical compound CCCCC1=CC=C(C)C(O)=C1CCCC SPSPIUSUWPLVKD-UHFFFAOYSA-N 0.000 description 1
- OBETXYAYXDNJHR-UHFFFAOYSA-N 2-Ethylhexanoic acid Chemical compound CCCCC(CC)C(O)=O OBETXYAYXDNJHR-UHFFFAOYSA-N 0.000 description 1
- JQXGCBKGIBTCHY-PDBXOOCHSA-N 2-HoTrE Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCC(O)C(O)=O JQXGCBKGIBTCHY-PDBXOOCHSA-N 0.000 description 1
- FKOKUHFZNIUSLW-UHFFFAOYSA-N 2-Hydroxypropyl stearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(C)O FKOKUHFZNIUSLW-UHFFFAOYSA-N 0.000 description 1
- IMSODMZESSGVBE-UHFFFAOYSA-N 2-Oxazoline Chemical compound C1CN=CO1 IMSODMZESSGVBE-UHFFFAOYSA-N 0.000 description 1
- DUMAFWZFOOOEPH-UHFFFAOYSA-N 2-[bis(2-hydroxyethyl)amino]ethanol;dodecyl benzenesulfonate Chemical compound OCCN(CCO)CCO.CCCCCCCCCCCCOS(=O)(=O)C1=CC=CC=C1 DUMAFWZFOOOEPH-UHFFFAOYSA-N 0.000 description 1
- 229940058020 2-amino-2-methyl-1-propanol Drugs 0.000 description 1
- UXFQFBNBSPQBJW-UHFFFAOYSA-N 2-amino-2-methylpropane-1,3-diol Chemical compound OCC(N)(C)CO UXFQFBNBSPQBJW-UHFFFAOYSA-N 0.000 description 1
- AJDLZUBEKJQNMJ-UHFFFAOYSA-N 2-amino-3-hydroxypropanoic acid ethanol Chemical compound CCO.OCC(N)C(O)=O AJDLZUBEKJQNMJ-UHFFFAOYSA-N 0.000 description 1
- ALMKBIQZBJUSQR-UHFFFAOYSA-N 2-aminoethanol;dodecane-1-sulfonic acid Chemical compound NCCO.CCCCCCCCCCCCS(O)(=O)=O ALMKBIQZBJUSQR-UHFFFAOYSA-N 0.000 description 1
- TWJNQYPJQDRXPH-UHFFFAOYSA-N 2-cyanobenzohydrazide Chemical compound NNC(=O)C1=CC=CC=C1C#N TWJNQYPJQDRXPH-UHFFFAOYSA-N 0.000 description 1
- HZLCGUXUOFWCCN-UHFFFAOYSA-N 2-hydroxynonadecane-1,2,3-tricarboxylic acid Chemical compound CCCCCCCCCCCCCCCCC(C(O)=O)C(O)(C(O)=O)CC(O)=O HZLCGUXUOFWCCN-UHFFFAOYSA-N 0.000 description 1
- AINHHRKKBHMHSN-UHFFFAOYSA-N 2-octadecan-2-yloxyoctadecane Chemical compound CCCCCCCCCCCCCCCCC(C)OC(C)CCCCCCCCCCCCCCCC AINHHRKKBHMHSN-UHFFFAOYSA-N 0.000 description 1
- XATHTZNVYDUDGS-UHFFFAOYSA-N 2-octadecylpropane-1,2,3-triol Chemical compound CCCCCCCCCCCCCCCCCCC(O)(CO)CO XATHTZNVYDUDGS-UHFFFAOYSA-N 0.000 description 1
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 description 1
- BPURNKBOSUCGAE-UHFFFAOYSA-N 2-oxopyrrolidine-1-sulfonic acid Chemical compound OS(=O)(=O)N1CCCC1=O BPURNKBOSUCGAE-UHFFFAOYSA-N 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 1
- 125000004042 4-aminobutyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])N([H])[H] 0.000 description 1
- HBTAOSGHCXUEKI-UHFFFAOYSA-N 4-chloro-n,n-dimethyl-3-nitrobenzenesulfonamide Chemical compound CN(C)S(=O)(=O)C1=CC=C(Cl)C([N+]([O-])=O)=C1 HBTAOSGHCXUEKI-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- 125000003143 4-hydroxybenzyl group Chemical group [H]C([*])([H])C1=C([H])C([H])=C(O[H])C([H])=C1[H] 0.000 description 1
- SJZRECIVHVDYJC-UHFFFAOYSA-N 4-hydroxybutyric acid Chemical compound OCCCC(O)=O SJZRECIVHVDYJC-UHFFFAOYSA-N 0.000 description 1
- 125000002373 5 membered heterocyclic group Chemical group 0.000 description 1
- GZJLLYHBALOKEX-UHFFFAOYSA-N 6-Ketone, O18-Me-Ussuriedine Natural products CC=CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O GZJLLYHBALOKEX-UHFFFAOYSA-N 0.000 description 1
- TUTVDOPAKOUNQV-UHFFFAOYSA-N 6-methyl-2-phenyl-1h-benzimidazole Chemical compound N1C2=CC(C)=CC=C2N=C1C1=CC=CC=C1 TUTVDOPAKOUNQV-UHFFFAOYSA-N 0.000 description 1
- OEOIWYCWCDBOPA-UHFFFAOYSA-N 6-methyl-heptanoic acid Chemical class CC(C)CCCCC(O)=O OEOIWYCWCDBOPA-UHFFFAOYSA-N 0.000 description 1
- ODMZDMMTKHXXKA-QXMHVHEDSA-N 8-methylnonyl (z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCCCCCCCC(C)C ODMZDMMTKHXXKA-QXMHVHEDSA-N 0.000 description 1
- 240000004731 Acer pseudoplatanus Species 0.000 description 1
- 235000002754 Acer pseudoplatanus Nutrition 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 1
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- 235000019489 Almond oil Nutrition 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 235000009328 Amaranthus caudatus Nutrition 0.000 description 1
- 240000001592 Amaranthus caudatus Species 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- DJHGAFSJWGLOIV-UHFFFAOYSA-N Arsenic acid Chemical compound O[As](O)(O)=O DJHGAFSJWGLOIV-UHFFFAOYSA-N 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- 235000012137 Atriplex confertifolia Nutrition 0.000 description 1
- 244000266618 Atriplex confertifolia Species 0.000 description 1
- 235000021537 Beetroot Nutrition 0.000 description 1
- 241001474374 Blennius Species 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- MRGBVKSDMXRZOY-UHFFFAOYSA-L C(CCC(=O)[O-])(=O)[O-].C(CCCCCCCCCCC)C(O)CN.[Na+].[Na+] Chemical compound C(CCC(=O)[O-])(=O)[O-].C(CCCCCCCCCCC)C(O)CN.[Na+].[Na+] MRGBVKSDMXRZOY-UHFFFAOYSA-L 0.000 description 1
- QTISETCSBFHXIK-UHFFFAOYSA-N C(CCCCCCCCCCC)[SiH]1[SiH2][SiH2][SiH2][SiH2][SiH2]1 Chemical compound C(CCCCCCCCCCC)[SiH]1[SiH2][SiH2][SiH2][SiH2][SiH2]1 QTISETCSBFHXIK-UHFFFAOYSA-N 0.000 description 1
- RRDSEKRNBORRPL-UHFFFAOYSA-N CCCCCCCCOC(=O)C=CC1=CC=C(C)C=C1 Chemical compound CCCCCCCCOC(=O)C=CC1=CC=C(C)C=C1 RRDSEKRNBORRPL-UHFFFAOYSA-N 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 235000012766 Cannabis sativa ssp. sativa var. sativa Nutrition 0.000 description 1
- 235000012765 Cannabis sativa ssp. sativa var. spontanea Nutrition 0.000 description 1
- 239000005632 Capric acid (CAS 334-48-5) Substances 0.000 description 1
- 239000005635 Caprylic acid (CAS 124-07-2) Substances 0.000 description 1
- KXDHJXZQYSOELW-UHFFFAOYSA-M Carbamate Chemical group NC([O-])=O KXDHJXZQYSOELW-UHFFFAOYSA-M 0.000 description 1
- 108010076119 Caseins Proteins 0.000 description 1
- 241000499489 Castor canadensis Species 0.000 description 1
- 235000003301 Ceiba pentandra Nutrition 0.000 description 1
- 244000146553 Ceiba pentandra Species 0.000 description 1
- 241000283153 Cetacea Species 0.000 description 1
- 240000003538 Chamaemelum nobile Species 0.000 description 1
- 235000007866 Chamaemelum nobile Nutrition 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 description 1
- 235000021513 Cinchona Nutrition 0.000 description 1
- 241000157855 Cinchona Species 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 240000004270 Colocasia esculenta var. antiquorum Species 0.000 description 1
- MDZRHDNUSKCTSP-UHFFFAOYSA-N Conamine Natural products C1C=C2CC(N)CCC2(C)C2C1C1CCC3C(C)N(C)CC31CC2 MDZRHDNUSKCTSP-UHFFFAOYSA-N 0.000 description 1
- AAWZDTNXLSGCEK-UHFFFAOYSA-N Cordycepinsaeure Natural products OC1CC(O)(C(O)=O)CC(O)C1O AAWZDTNXLSGCEK-UHFFFAOYSA-N 0.000 description 1
- 240000008067 Cucumis sativus Species 0.000 description 1
- 235000010799 Cucumis sativus var sativus Nutrition 0.000 description 1
- 235000007129 Cuminum cyminum Nutrition 0.000 description 1
- 244000304337 Cuminum cyminum Species 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- 241000645874 Cymbopogon refractus Species 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- RBNPOMFGQQGHHO-UWTATZPHSA-N D-glyceric acid Chemical compound OC[C@@H](O)C(O)=O RBNPOMFGQQGHHO-UWTATZPHSA-N 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 235000002723 Dioscorea alata Nutrition 0.000 description 1
- 235000007056 Dioscorea composita Nutrition 0.000 description 1
- 235000009723 Dioscorea convolvulacea Nutrition 0.000 description 1
- 235000005362 Dioscorea floribunda Nutrition 0.000 description 1
- 235000004868 Dioscorea macrostachya Nutrition 0.000 description 1
- 235000005361 Dioscorea nummularia Nutrition 0.000 description 1
- 235000005360 Dioscorea spiculiflora Nutrition 0.000 description 1
- 240000005153 Dodonaea viscosa Species 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 102000010911 Enzyme Precursors Human genes 0.000 description 1
- 108010062466 Enzyme Precursors Proteins 0.000 description 1
- 241000402754 Erythranthe moschata Species 0.000 description 1
- BFPYWIDHMRZLRN-SLHNCBLASA-N Ethinyl estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 BFPYWIDHMRZLRN-SLHNCBLASA-N 0.000 description 1
- 239000001856 Ethyl cellulose Substances 0.000 description 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
- FPVVYTCTZKCSOJ-UHFFFAOYSA-N Ethylene glycol distearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCOC(=O)CCCCCCCCCCCCCCCCC FPVVYTCTZKCSOJ-UHFFFAOYSA-N 0.000 description 1
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 1
- 244000004281 Eucalyptus maculata Species 0.000 description 1
- PNKUSGQVOMIXLU-UHFFFAOYSA-N Formamidine Chemical compound NC=N PNKUSGQVOMIXLU-UHFFFAOYSA-N 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- DSLZVSRJTYRBFB-UHFFFAOYSA-N Galactaric acid Natural products OC(=O)C(O)C(O)C(O)C(O)C(O)=O DSLZVSRJTYRBFB-UHFFFAOYSA-N 0.000 description 1
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- YXHVCZZLWZYHSA-FPLPWBNLSA-N Ginkgoic acid Chemical compound CCCCCC\C=C/CCCCCCCC1=CC=CC(O)=C1C(O)=O YXHVCZZLWZYHSA-FPLPWBNLSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 241000208680 Hamamelis mollis Species 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- CMBYOWLFQAFZCP-UHFFFAOYSA-N Hexyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCCCCCC CMBYOWLFQAFZCP-UHFFFAOYSA-N 0.000 description 1
- 101000856199 Homo sapiens Chymotrypsin-like protease CTRL-1 Proteins 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 239000004169 Hydrogenated Poly-1-Decene Substances 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- IMQLKJBTEOYOSI-GPIVLXJGSA-N Inositol-hexakisphosphate Chemical compound OP(O)(=O)O[C@H]1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=O IMQLKJBTEOYOSI-GPIVLXJGSA-N 0.000 description 1
- 235000006350 Ipomoea batatas var. batatas Nutrition 0.000 description 1
- 241000721662 Juniperus Species 0.000 description 1
- 150000008575 L-amino acids Chemical class 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- BVHLGVCQOALMSV-JEDNCBNOSA-N L-lysine hydrochloride Chemical compound Cl.NCCCC[C@H](N)C(O)=O BVHLGVCQOALMSV-JEDNCBNOSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 235000017858 Laurus nobilis Nutrition 0.000 description 1
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- 229920000161 Locust bean gum Polymers 0.000 description 1
- 244000280244 Luffa acutangula Species 0.000 description 1
- 235000009814 Luffa aegyptiaca Nutrition 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 235000007232 Matricaria chamomilla Nutrition 0.000 description 1
- 235000011779 Menyanthes trifoliata Nutrition 0.000 description 1
- UEZVMMHDMIWARA-UHFFFAOYSA-N Metaphosphoric acid Chemical compound OP(=O)=O UEZVMMHDMIWARA-UHFFFAOYSA-N 0.000 description 1
- 235000008708 Morus alba Nutrition 0.000 description 1
- 240000000249 Morus alba Species 0.000 description 1
- 235000012851 Myrica pensylvanica Nutrition 0.000 description 1
- 235000021360 Myristic acid Nutrition 0.000 description 1
- QZXSMBBFBXPQHI-UHFFFAOYSA-N N-(dodecanoyl)ethanolamine Chemical compound CCCCCCCCCCCC(=O)NCCO QZXSMBBFBXPQHI-UHFFFAOYSA-N 0.000 description 1
- DEOKQQMXDZJSOY-RJXKWAGSSA-M N[C@@H](CCC(=O)O)C(=O)[O-].C(CCCCCCCCCCC)(=O)O.[Na+] Chemical compound N[C@@H](CCC(=O)O)C(=O)[O-].C(CCCCCCCCCCC)(=O)O.[Na+] DEOKQQMXDZJSOY-RJXKWAGSSA-M 0.000 description 1
- XYCBMTYEYMEOOG-XYDYARRRSA-L N[C@@H](CCC(=O)[O-])C(=O)OCCCCCCCCCCCCCCCCCC.[Na+].[Na+].C(CCCCCCCCCCCCCCCCC)OC([C@@H](N)CCC(=O)[O-])=O Chemical compound N[C@@H](CCC(=O)[O-])C(=O)OCCCCCCCCCCCCCCCCCC.[Na+].[Na+].C(CCCCCCCCCCCCCCCCC)OC([C@@H](N)CCC(=O)[O-])=O XYCBMTYEYMEOOG-XYDYARRRSA-L 0.000 description 1
- 241000772415 Neovison vison Species 0.000 description 1
- 239000000020 Nitrocellulose Substances 0.000 description 1
- XOJVVFBFDXDTEG-UHFFFAOYSA-N Norphytane Natural products CC(C)CCCC(C)CCCC(C)CCCC(C)C XOJVVFBFDXDTEG-UHFFFAOYSA-N 0.000 description 1
- 241000209490 Nymphaea Species 0.000 description 1
- 235000016791 Nymphaea odorata subsp odorata Nutrition 0.000 description 1
- 244000227633 Ocotea pretiosa Species 0.000 description 1
- 235000004263 Ocotea pretiosa Nutrition 0.000 description 1
- 241000219925 Oenothera Species 0.000 description 1
- 235000004496 Oenothera biennis Nutrition 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 239000002033 PVDF binder Substances 0.000 description 1
- 235000006484 Paeonia officinalis Nutrition 0.000 description 1
- 244000170916 Paeonia officinalis Species 0.000 description 1
- 240000004370 Pastinaca sativa Species 0.000 description 1
- 235000017769 Pastinaca sativa subsp sativa Nutrition 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- 241000287463 Phalacrocorax Species 0.000 description 1
- IMQLKJBTEOYOSI-UHFFFAOYSA-N Phytic acid Natural products OP(O)(=O)OC1C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C1OP(O)(O)=O IMQLKJBTEOYOSI-UHFFFAOYSA-N 0.000 description 1
- 235000006485 Platanus occidentalis Nutrition 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 229920002873 Polyethylenimine Polymers 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 239000004260 Potassium ascorbate Substances 0.000 description 1
- 235000016311 Primula vulgaris Nutrition 0.000 description 1
- 244000028344 Primula vulgaris Species 0.000 description 1
- 235000001630 Pyrus pyrifolia var culta Nutrition 0.000 description 1
- 240000002609 Pyrus pyrifolia var. culta Species 0.000 description 1
- AAWZDTNXLSGCEK-ZHQZDSKASA-N Quinic acid Natural products O[C@H]1CC(O)(C(O)=O)C[C@H](O)C1O AAWZDTNXLSGCEK-ZHQZDSKASA-N 0.000 description 1
- 235000019484 Rapeseed oil Nutrition 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 241000220317 Rosa Species 0.000 description 1
- 240000007651 Rubus glaucus Species 0.000 description 1
- 235000011034 Rubus glaucus Nutrition 0.000 description 1
- 235000009122 Rubus idaeus Nutrition 0.000 description 1
- 240000000111 Saccharum officinarum Species 0.000 description 1
- 235000007201 Saccharum officinarum Nutrition 0.000 description 1
- 235000019485 Safflower oil Nutrition 0.000 description 1
- 241001647091 Saxifraga granulata Species 0.000 description 1
- SZKKRCSOSQAJDE-UHFFFAOYSA-N Schradan Chemical group CN(C)P(=O)(N(C)C)OP(=O)(N(C)C)N(C)C SZKKRCSOSQAJDE-UHFFFAOYSA-N 0.000 description 1
- 241000239226 Scorpiones Species 0.000 description 1
- 229920002385 Sodium hyaluronate Polymers 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- IYFATESGLOUGBX-YVNJGZBMSA-N Sorbitan monopalmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O IYFATESGLOUGBX-YVNJGZBMSA-N 0.000 description 1
- 239000004147 Sorbitan trioleate Substances 0.000 description 1
- PRXRUNOAOLTIEF-ADSICKODSA-N Sorbitan trioleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](OC(=O)CCCCCCC\C=C/CCCCCCCC)[C@H]1OC[C@H](O)[C@H]1OC(=O)CCCCCCC\C=C/CCCCCCCC PRXRUNOAOLTIEF-ADSICKODSA-N 0.000 description 1
- VBIIFPGSPJYLRR-UHFFFAOYSA-M Stearyltrimethylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)C VBIIFPGSPJYLRR-UHFFFAOYSA-M 0.000 description 1
- PJANXHGTPQOBST-VAWYXSNFSA-N Stilbene Natural products C=1C=CC=CC=1/C=C/C1=CC=CC=C1 PJANXHGTPQOBST-VAWYXSNFSA-N 0.000 description 1
- 244000028419 Styrax benzoin Species 0.000 description 1
- 235000000126 Styrax benzoin Nutrition 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 235000008411 Sumatra benzointree Nutrition 0.000 description 1
- 235000019486 Sunflower oil Nutrition 0.000 description 1
- 235000005212 Terminalia tomentosa Nutrition 0.000 description 1
- 244000125380 Terminalia tomentosa Species 0.000 description 1
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 1
- 241001122767 Theaceae Species 0.000 description 1
- 235000007303 Thymus vulgaris Nutrition 0.000 description 1
- 240000002657 Thymus vulgaris Species 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108060005989 Tryptase Proteins 0.000 description 1
- 102000001400 Tryptase Human genes 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 240000000059 Vitex cofassus Species 0.000 description 1
- 244000195452 Wasabia japonica Species 0.000 description 1
- 235000000760 Wasabia japonica Nutrition 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- NCHJGQKLPRTMAO-XWVZOOPGSA-N [(2R)-2-[(2R,3R,4S)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyethyl] 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O NCHJGQKLPRTMAO-XWVZOOPGSA-N 0.000 description 1
- WERKSKAQRVDLDW-ANOHMWSOSA-N [(2s,3r,4r,5r)-2,3,4,5,6-pentahydroxyhexyl] (z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO WERKSKAQRVDLDW-ANOHMWSOSA-N 0.000 description 1
- FJWGYAHXMCUOOM-QHOUIDNNSA-N [(2s,3r,4s,5r,6r)-2-[(2r,3r,4s,5r,6s)-4,5-dinitrooxy-2-(nitrooxymethyl)-6-[(2r,3r,4s,5r,6s)-4,5,6-trinitrooxy-2-(nitrooxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-3,5-dinitrooxy-6-(nitrooxymethyl)oxan-4-yl] nitrate Chemical compound O([C@@H]1O[C@@H]([C@H]([C@H](O[N+]([O-])=O)[C@H]1O[N+]([O-])=O)O[C@H]1[C@@H]([C@@H](O[N+]([O-])=O)[C@H](O[N+]([O-])=O)[C@@H](CO[N+]([O-])=O)O1)O[N+]([O-])=O)CO[N+](=O)[O-])[C@@H]1[C@@H](CO[N+]([O-])=O)O[C@@H](O[N+]([O-])=O)[C@H](O[N+]([O-])=O)[C@H]1O[N+]([O-])=O FJWGYAHXMCUOOM-QHOUIDNNSA-N 0.000 description 1
- DRRMRHKHTQRWMB-UHFFFAOYSA-N [3-(2-ethylhexanoyloxy)-2,2-bis(2-ethylhexanoyloxymethyl)propyl] 2-ethylhexanoate Chemical compound CCCCC(CC)C(=O)OCC(COC(=O)C(CC)CCCC)(COC(=O)C(CC)CCCC)COC(=O)C(CC)CCCC DRRMRHKHTQRWMB-UHFFFAOYSA-N 0.000 description 1
- KWVFUTDPKIKVQW-UHFFFAOYSA-N [Sr].[Na] Chemical compound [Sr].[Na] KWVFUTDPKIKVQW-UHFFFAOYSA-N 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 229940022663 acetate Drugs 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- MOOSBPSAZDOBSN-UHFFFAOYSA-N acetic acid;azane Chemical compound N.CC(O)=O.CC(O)=O.CC(O)=O.CC(O)=O.CC(O)=O MOOSBPSAZDOBSN-UHFFFAOYSA-N 0.000 description 1
- VYTBPJNGNGMRFH-UHFFFAOYSA-N acetic acid;azane Chemical compound N.N.CC(O)=O.CC(O)=O.CC(O)=O.CC(O)=O VYTBPJNGNGMRFH-UHFFFAOYSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000001361 adipic acid Substances 0.000 description 1
- 235000011037 adipic acid Nutrition 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 229940040563 agaric acid Drugs 0.000 description 1
- 238000005054 agglomeration Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 125000003172 aldehyde group Chemical group 0.000 description 1
- IAJILQKETJEXLJ-RSJOWCBRSA-N aldehydo-D-galacturonic acid Chemical compound O=C[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-RSJOWCBRSA-N 0.000 description 1
- 229920000180 alkyd Polymers 0.000 description 1
- 150000005215 alkyl ethers Chemical class 0.000 description 1
- 125000005037 alkyl phenyl group Chemical group 0.000 description 1
- 125000005211 alkyl trimethyl ammonium group Chemical group 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- 239000008168 almond oil Substances 0.000 description 1
- 229940069521 aloe extract Drugs 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- SNAAJJQQZSMGQD-UHFFFAOYSA-N aluminum magnesium Chemical compound [Mg].[Al] SNAAJJQQZSMGQD-UHFFFAOYSA-N 0.000 description 1
- 239000004178 amaranth Substances 0.000 description 1
- 235000012735 amaranth Nutrition 0.000 description 1
- 150000001409 amidines Chemical class 0.000 description 1
- 150000003862 amino acid derivatives Chemical class 0.000 description 1
- 229960004050 aminobenzoic acid Drugs 0.000 description 1
- CBTVGIZVANVGBH-UHFFFAOYSA-N aminomethyl propanol Chemical compound CC(C)(N)CO CBTVGIZVANVGBH-UHFFFAOYSA-N 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 239000010775 animal oil Substances 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000010477 apricot oil Substances 0.000 description 1
- 229940114079 arachidonic acid Drugs 0.000 description 1
- 235000021342 arachidonic acid Nutrition 0.000 description 1
- BTFJIXJJCSYFAL-UHFFFAOYSA-N arachidyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 229940000488 arsenic acid Drugs 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- 239000000305 astragalus gummifer gum Substances 0.000 description 1
- 239000003212 astringent agent Substances 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- JPNZKPRONVOMLL-UHFFFAOYSA-N azane;octadecanoic acid Chemical class [NH4+].CCCCCCCCCCCCCCCCCC([O-])=O JPNZKPRONVOMLL-UHFFFAOYSA-N 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 229960002130 benzoin Drugs 0.000 description 1
- QRUDEWIWKLJBPS-UHFFFAOYSA-N benzotriazole Chemical compound C1=CC=C2N[N][N]C2=C1 QRUDEWIWKLJBPS-UHFFFAOYSA-N 0.000 description 1
- 239000012964 benzotriazole Substances 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- 229950004580 benzyl nicotinate Drugs 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 235000010290 biphenyl Nutrition 0.000 description 1
- HGKOWIQVWAQWDS-UHFFFAOYSA-N bis(16-methylheptadecyl) 2-hydroxybutanedioate Chemical compound CC(C)CCCCCCCCCCCCCCCOC(=O)CC(O)C(=O)OCCCCCCCCCCCCCCCC(C)C HGKOWIQVWAQWDS-UHFFFAOYSA-N 0.000 description 1
- 239000001273 butane Substances 0.000 description 1
- CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 description 1
- UTMTYYKGLQURCK-UHFFFAOYSA-N butane-1,3-diol;propane-1,2,3-triol Chemical compound CC(O)CCO.OCC(O)CO UTMTYYKGLQURCK-UHFFFAOYSA-N 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 description 1
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 1
- 229940074360 caffeic acid Drugs 0.000 description 1
- 235000004883 caffeic acid Nutrition 0.000 description 1
- 235000009120 camo Nutrition 0.000 description 1
- 229960000846 camphor Drugs 0.000 description 1
- 229930008380 camphor Natural products 0.000 description 1
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 description 1
- 125000001951 carbamoylamino group Chemical group C(N)(=O)N* 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 229920006317 cationic polymer Polymers 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 235000005607 chanvre indien Nutrition 0.000 description 1
- 235000009347 chasteberry Nutrition 0.000 description 1
- 229960003260 chlorhexidine Drugs 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- KXKPYJOVDUMHGS-OSRGNVMNSA-N chondroitin sulfate Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](OS(O)(=O)=O)[C@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](C(O)=O)O1 KXKPYJOVDUMHGS-OSRGNVMNSA-N 0.000 description 1
- 229940114081 cinnamate Drugs 0.000 description 1
- 239000010630 cinnamon oil Substances 0.000 description 1
- QAIPRVGONGVQAS-UHFFFAOYSA-N cis-caffeic acid Natural products OC(=O)C=CC1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-UHFFFAOYSA-N 0.000 description 1
- 235000012716 cod liver oil Nutrition 0.000 description 1
- 239000003026 cod liver oil Substances 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 210000000736 corneocyte Anatomy 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 230000000875 corresponding effect Effects 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 239000002385 cottonseed oil Substances 0.000 description 1
- 235000019383 crystalline wax Nutrition 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 229940003092 decanoic acid Drugs 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 230000032798 delamination Effects 0.000 description 1
- 150000005690 diesters Chemical class 0.000 description 1
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
- BZCOSCNPHJNQBP-OWOJBTEDSA-N dihydroxyfumaric acid Chemical compound OC(=O)C(\O)=C(/O)C(O)=O BZCOSCNPHJNQBP-OWOJBTEDSA-N 0.000 description 1
- 229940031578 diisopropyl adipate Drugs 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- REZZEXDLIUJMMS-UHFFFAOYSA-M dimethyldioctadecylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)CCCCCCCCCCCCCCCCCC REZZEXDLIUJMMS-UHFFFAOYSA-M 0.000 description 1
- 108700003601 dimethylglycine Proteins 0.000 description 1
- 235000004879 dioscorea Nutrition 0.000 description 1
- 235000021186 dishes Nutrition 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000004664 distearyldimethylammonium chloride (DHTDMAC) Substances 0.000 description 1
- 235000020669 docosahexaenoic acid Nutrition 0.000 description 1
- KAUVQQXNCKESLC-UHFFFAOYSA-N docosahexaenoic acid (DHA) Natural products COC(=O)C(C)NOCC1=CC=CC=C1 KAUVQQXNCKESLC-UHFFFAOYSA-N 0.000 description 1
- BHCBQALBZYVPNR-UHFFFAOYSA-N dodecyl 2-amino-2-methylpropanoate Chemical compound CCCCCCCCCCCCOC(=O)C(C)(C)N BHCBQALBZYVPNR-UHFFFAOYSA-N 0.000 description 1
- DDXLVDQZPFLQMZ-UHFFFAOYSA-M dodecyl(trimethyl)azanium;chloride Chemical compound [Cl-].CCCCCCCCCCCC[N+](C)(C)C DDXLVDQZPFLQMZ-UHFFFAOYSA-M 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 238000001493 electron microscopy Methods 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 239000010696 ester oil Substances 0.000 description 1
- 229930182833 estradiol Natural products 0.000 description 1
- 229960005309 estradiol Drugs 0.000 description 1
- CCIVGXIOQKPBKL-UHFFFAOYSA-M ethanesulfonate Chemical compound CCS([O-])(=O)=O CCIVGXIOQKPBKL-UHFFFAOYSA-M 0.000 description 1
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
- 229960002568 ethinylestradiol Drugs 0.000 description 1
- 235000019325 ethyl cellulose Nutrition 0.000 description 1
- 229920001249 ethyl cellulose Polymers 0.000 description 1
- TVQGDYNRXLTQAP-UHFFFAOYSA-N ethyl heptanoate Chemical compound CCCCCCC(=O)OCC TVQGDYNRXLTQAP-UHFFFAOYSA-N 0.000 description 1
- 239000004403 ethyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 description 1
- OUDSFQBUEBFSPS-UHFFFAOYSA-N ethylenediaminetriacetic acid Chemical compound OC(=O)CNCCN(CC(O)=O)CC(O)=O OUDSFQBUEBFSPS-UHFFFAOYSA-N 0.000 description 1
- 235000008524 evening primrose extract Nutrition 0.000 description 1
- 239000010475 evening primrose oil Substances 0.000 description 1
- 229940089020 evening primrose oil Drugs 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- RMBPEFMHABBEKP-UHFFFAOYSA-N fluorene Chemical compound C1=CC=C2C3=C[CH]C=CC3=CC2=C1 RMBPEFMHABBEKP-UHFFFAOYSA-N 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 230000000855 fungicidal effect Effects 0.000 description 1
- 239000000417 fungicide Substances 0.000 description 1
- DSLZVSRJTYRBFB-DUHBMQHGSA-N galactaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)C(O)=O DSLZVSRJTYRBFB-DUHBMQHGSA-N 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 229940074391 gallic acid Drugs 0.000 description 1
- 235000004515 gallic acid Nutrition 0.000 description 1
- VZCCETWTMQHEPK-QNEBEIHSSA-N gamma-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCC(O)=O VZCCETWTMQHEPK-QNEBEIHSSA-N 0.000 description 1
- 238000002309 gasification Methods 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000000451 gelidium spp. gum Substances 0.000 description 1
- 229960005219 gentisic acid Drugs 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 1
- 229940046257 glyceryl phosphate Drugs 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 239000001649 glycyrrhiza glabra l. absolute Substances 0.000 description 1
- 239000001685 glycyrrhizic acid Substances 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 230000036449 good health Effects 0.000 description 1
- 235000019382 gum benzoic Nutrition 0.000 description 1
- 230000036074 healthy skin Effects 0.000 description 1
- KWLMIXQRALPRBC-UHFFFAOYSA-L hectorite Chemical compound [Li+].[OH-].[OH-].[Na+].[Mg+2].O1[Si]2([O-])O[Si]1([O-])O[Si]([O-])(O1)O[Si]1([O-])O2 KWLMIXQRALPRBC-UHFFFAOYSA-L 0.000 description 1
- 229910000271 hectorite Inorganic materials 0.000 description 1
- 239000011487 hemp Substances 0.000 description 1
- DWMMZQMXUWUJME-UHFFFAOYSA-N hexadecyl octanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)CCCCCCC DWMMZQMXUWUJME-UHFFFAOYSA-N 0.000 description 1
- WNLRTRBMVRJNCN-UHFFFAOYSA-N hexanedioic acid Natural products OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 1
- 229940100463 hexyl laurate Drugs 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 238000000265 homogenisation Methods 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- ZXRCAYWYTOIRQS-UHFFFAOYSA-N hydron;phenol;chloride Chemical compound Cl.OC1=CC=CC=C1 ZXRCAYWYTOIRQS-UHFFFAOYSA-N 0.000 description 1
- 239000001341 hydroxy propyl starch Substances 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000013828 hydroxypropyl starch Nutrition 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 229940078545 isocetyl stearate Drugs 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 229940093629 isopropyl isostearate Drugs 0.000 description 1
- 150000004715 keto acids Chemical class 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 229940094522 laponite Drugs 0.000 description 1
- 239000010985 leather Substances 0.000 description 1
- 229940051810 licorice root extract Drugs 0.000 description 1
- 235000020725 licorice root extract Nutrition 0.000 description 1
- 235000021388 linseed oil Nutrition 0.000 description 1
- 239000000944 linseed oil Substances 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- XCOBTUNSZUJCDH-UHFFFAOYSA-B lithium magnesium sodium silicate Chemical compound [Li+].[Li+].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[Na+].[Na+].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3 XCOBTUNSZUJCDH-UHFFFAOYSA-B 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 235000010420 locust bean gum Nutrition 0.000 description 1
- 239000000711 locust bean gum Substances 0.000 description 1
- 239000004137 magnesium phosphate Substances 0.000 description 1
- 229960002261 magnesium phosphate Drugs 0.000 description 1
- 229910000157 magnesium phosphate Inorganic materials 0.000 description 1
- 235000010994 magnesium phosphates Nutrition 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 229940049920 malate Drugs 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N malic acid Chemical compound OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- 229960002160 maltose Drugs 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 229940098779 methanesulfonic acid Drugs 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 125000000250 methylamino group Chemical group [H]N(*)C([H])([H])[H] 0.000 description 1
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 235000021243 milk fat Nutrition 0.000 description 1
- XONPDZSGENTBNJ-UHFFFAOYSA-N molecular hydrogen;sodium Chemical compound [Na].[H][H] XONPDZSGENTBNJ-UHFFFAOYSA-N 0.000 description 1
- 150000004682 monohydrates Chemical class 0.000 description 1
- 239000012170 montan wax Substances 0.000 description 1
- 229940043348 myristyl alcohol Drugs 0.000 description 1
- VMGAPWLDMVPYIA-HIDZBRGKSA-N n'-amino-n-iminomethanimidamide Chemical compound N\N=C\N=N VMGAPWLDMVPYIA-HIDZBRGKSA-N 0.000 description 1
- DAZXVJBJRMWXJP-UHFFFAOYSA-N n,n-dimethylethylamine Chemical compound CCN(C)C DAZXVJBJRMWXJP-UHFFFAOYSA-N 0.000 description 1
- 229940078490 n,n-dimethylglycine Drugs 0.000 description 1
- AMQJEAYHLZJPGS-UHFFFAOYSA-N n-butyl carbinol Natural products CCCCCO AMQJEAYHLZJPGS-UHFFFAOYSA-N 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001280 n-hexyl group Chemical group C(CCCCC)* 0.000 description 1
- RIWRFSMVIUAEBX-UHFFFAOYSA-N n-methyl-1-phenylmethanamine Chemical class CNCC1=CC=CC=C1 RIWRFSMVIUAEBX-UHFFFAOYSA-N 0.000 description 1
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 229920001220 nitrocellulos Polymers 0.000 description 1
- 229940079938 nitrocellulose Drugs 0.000 description 1
- GSGDTSDELPUTKU-UHFFFAOYSA-N nonoxybenzene Chemical compound CCCCCCCCCOC1=CC=CC=C1 GSGDTSDELPUTKU-UHFFFAOYSA-N 0.000 description 1
- 235000019488 nut oil Nutrition 0.000 description 1
- 239000010466 nut oil Substances 0.000 description 1
- NIHNNTQXNPWCJQ-UHFFFAOYSA-N o-biphenylenemethane Natural products C1=CC=C2CC3=CC=CC=C3C2=C1 NIHNNTQXNPWCJQ-UHFFFAOYSA-N 0.000 description 1
- ZWLPBLYKEWSWPD-UHFFFAOYSA-N o-toluic acid Chemical compound CC1=CC=CC=C1C(O)=O ZWLPBLYKEWSWPD-UHFFFAOYSA-N 0.000 description 1
- CKQVRZJOMJRTOY-UHFFFAOYSA-N octadecanoic acid;propane-1,2,3-triol Chemical compound OCC(O)CO.CCCCCCCCCCCCCCCCCC(O)=O CKQVRZJOMJRTOY-UHFFFAOYSA-N 0.000 description 1
- IEDOGKKOPNRRKW-UHFFFAOYSA-N octadecyl tetradecanoate Chemical compound CCCCCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCC IEDOGKKOPNRRKW-UHFFFAOYSA-N 0.000 description 1
- KSCKTBJJRVPGKM-UHFFFAOYSA-N octan-1-olate;titanium(4+) Chemical compound [Ti+4].CCCCCCCC[O-].CCCCCCCC[O-].CCCCCCCC[O-].CCCCCCCC[O-] KSCKTBJJRVPGKM-UHFFFAOYSA-N 0.000 description 1
- 229960002446 octanoic acid Drugs 0.000 description 1
- 229960003921 octisalate Drugs 0.000 description 1
- ZPIRTVJRHUMMOI-UHFFFAOYSA-N octoxybenzene Chemical compound CCCCCCCCOC1=CC=CC=C1 ZPIRTVJRHUMMOI-UHFFFAOYSA-N 0.000 description 1
- WCJLCOAEJIHPCW-UHFFFAOYSA-N octyl 2-hydroxybenzoate Chemical compound CCCCCCCCOC(=O)C1=CC=CC=C1O WCJLCOAEJIHPCW-UHFFFAOYSA-N 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 229960005010 orotic acid Drugs 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 210000003254 palate Anatomy 0.000 description 1
- 150000002942 palmitic acid derivatives Chemical class 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 229960000969 phenyl salicylate Drugs 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N phenylbenzene Natural products C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 description 1
- VYMDGNCVAMGZFE-UHFFFAOYSA-N phenylbutazonum Chemical compound O=C1C(CCCC)C(=O)N(C=2C=CC=CC=2)N1C1=CC=CC=C1 VYMDGNCVAMGZFE-UHFFFAOYSA-N 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 150000004714 phosphonium salts Chemical class 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 239000000467 phytic acid Substances 0.000 description 1
- 229940068041 phytic acid Drugs 0.000 description 1
- 235000002949 phytic acid Nutrition 0.000 description 1
- 229940068065 phytosterols Drugs 0.000 description 1
- 230000003169 placental effect Effects 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 description 1
- 229920002432 poly(vinyl methyl ether) polymer Polymers 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 229920000768 polyamine Polymers 0.000 description 1
- 229920000223 polyglycerol Polymers 0.000 description 1
- 229920000137 polyphosphoric acid Polymers 0.000 description 1
- 229920001709 polysilazane Polymers 0.000 description 1
- 229920002981 polyvinylidene fluoride Polymers 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 229940017794 potassium ascorbate Drugs 0.000 description 1
- 159000000001 potassium salts Chemical class 0.000 description 1
- LQAZPMXASFNKCD-UHFFFAOYSA-M potassium;dodecane-1-sulfonate Chemical compound [K+].CCCCCCCCCCCCS([O-])(=O)=O LQAZPMXASFNKCD-UHFFFAOYSA-M 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- NEOZOXKVMDBOSG-UHFFFAOYSA-N propan-2-yl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OC(C)C NEOZOXKVMDBOSG-UHFFFAOYSA-N 0.000 description 1
- OBIOUMHEIQQDFV-UHFFFAOYSA-N propan-2-yl 3-(4-methylphenyl)prop-2-enoate Chemical compound CC(C)OC(=O)C=CC1=CC=C(C)C=C1 OBIOUMHEIQQDFV-UHFFFAOYSA-N 0.000 description 1
- 125000001501 propionyl group Chemical group O=C([*])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229940093625 propylene glycol monostearate Drugs 0.000 description 1
- QJZUKDFHGGYHMC-UHFFFAOYSA-N pyridine-3-carbaldehyde Chemical compound O=CC1=CC=CN=C1 QJZUKDFHGGYHMC-UHFFFAOYSA-N 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- BOLDJAUMGUJJKM-LSDHHAIUSA-N renifolin D Natural products CC(=C)[C@@H]1Cc2c(O)c(O)ccc2[C@H]1CC(=O)c3ccc(O)cc3O BOLDJAUMGUJJKM-LSDHHAIUSA-N 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 235000020944 retinol Nutrition 0.000 description 1
- 239000011607 retinol Substances 0.000 description 1
- 229960003471 retinol Drugs 0.000 description 1
- 235000019172 retinyl palmitate Nutrition 0.000 description 1
- 239000011769 retinyl palmitate Substances 0.000 description 1
- 229940108325 retinyl palmitate Drugs 0.000 description 1
- WBHHMMIMDMUBKC-XLNAKTSKSA-N ricinelaidic acid Chemical compound CCCCCC[C@@H](O)C\C=C\CCCCCCCC(O)=O WBHHMMIMDMUBKC-XLNAKTSKSA-N 0.000 description 1
- 229960003656 ricinoleic acid Drugs 0.000 description 1
- FEUQNCSVHBHROZ-UHFFFAOYSA-N ricinoleic acid Natural products CCCCCCC(O[Si](C)(C)C)CC=CCCCCCCCC(=O)OC FEUQNCSVHBHROZ-UHFFFAOYSA-N 0.000 description 1
- 235000005713 safflower oil Nutrition 0.000 description 1
- 239000003813 safflower oil Substances 0.000 description 1
- 229940112950 sage extract Drugs 0.000 description 1
- 235000020752 sage extract Nutrition 0.000 description 1
- 229960001860 salicylate Drugs 0.000 description 1
- YGSDEFSMJLZEOE-UHFFFAOYSA-M salicylate Chemical compound OC1=CC=CC=C1C([O-])=O YGSDEFSMJLZEOE-UHFFFAOYSA-M 0.000 description 1
- 239000012723 sample buffer Substances 0.000 description 1
- 235000003441 saturated fatty acids Nutrition 0.000 description 1
- 150000004671 saturated fatty acids Chemical class 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 239000012176 shellac wax Substances 0.000 description 1
- JXOHGGNKMLTUBP-HSUXUTPPSA-N shikimic acid Chemical compound O[C@@H]1CC(C(O)=O)=C[C@@H](O)[C@H]1O JXOHGGNKMLTUBP-HSUXUTPPSA-N 0.000 description 1
- JXOHGGNKMLTUBP-JKUQZMGJSA-N shikimic acid Natural products O[C@@H]1CC(C(O)=O)=C[C@H](O)[C@@H]1O JXOHGGNKMLTUBP-JKUQZMGJSA-N 0.000 description 1
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 229920002379 silicone rubber Polymers 0.000 description 1
- 239000004945 silicone rubber Substances 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 206010040882 skin lesion Diseases 0.000 description 1
- 231100000444 skin lesion Toxicity 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- BTURAGWYSMTVOW-UHFFFAOYSA-M sodium dodecanoate Chemical compound [Na+].CCCCCCCCCCCC([O-])=O BTURAGWYSMTVOW-UHFFFAOYSA-M 0.000 description 1
- FZHLWVUAICIIPW-UHFFFAOYSA-M sodium gallate Chemical compound [Na+].OC1=CC(C([O-])=O)=CC(O)=C1O FZHLWVUAICIIPW-UHFFFAOYSA-M 0.000 description 1
- 229940010747 sodium hyaluronate Drugs 0.000 description 1
- 229910000104 sodium hydride Inorganic materials 0.000 description 1
- 239000012312 sodium hydride Substances 0.000 description 1
- 239000001540 sodium lactate Substances 0.000 description 1
- 229940005581 sodium lactate Drugs 0.000 description 1
- 235000011088 sodium lactate Nutrition 0.000 description 1
- 229940082004 sodium laurate Drugs 0.000 description 1
- 229940079862 sodium lauryl sarcosinate Drugs 0.000 description 1
- 229940045870 sodium palmitate Drugs 0.000 description 1
- 229960003339 sodium phosphate Drugs 0.000 description 1
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 description 1
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 1
- ADWNFGORSPBALY-UHFFFAOYSA-M sodium;2-[dodecyl(methyl)amino]acetate Chemical compound [Na+].CCCCCCCCCCCCN(C)CC([O-])=O ADWNFGORSPBALY-UHFFFAOYSA-M 0.000 description 1
- GGXKEBACDBNFAF-UHFFFAOYSA-M sodium;hexadecanoate Chemical compound [Na+].CCCCCCCCCCCCCCCC([O-])=O GGXKEBACDBNFAF-UHFFFAOYSA-M 0.000 description 1
- 239000004334 sorbic acid Substances 0.000 description 1
- 235000010199 sorbic acid Nutrition 0.000 description 1
- 229940075582 sorbic acid Drugs 0.000 description 1
- 229940100515 sorbitan Drugs 0.000 description 1
- 235000011071 sorbitan monopalmitate Nutrition 0.000 description 1
- 239000001570 sorbitan monopalmitate Substances 0.000 description 1
- 229940031953 sorbitan monopalmitate Drugs 0.000 description 1
- 235000019337 sorbitan trioleate Nutrition 0.000 description 1
- 229960000391 sorbitan trioleate Drugs 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 229940031439 squalene Drugs 0.000 description 1
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 1
- 229920003179 starch-based polymer Polymers 0.000 description 1
- 239000004628 starch-based polymer Substances 0.000 description 1
- 229940094908 stearyl myristate Drugs 0.000 description 1
- PJANXHGTPQOBST-UHFFFAOYSA-N stilbene Chemical compound C=1C=CC=CC=1C=CC1=CC=CC=C1 PJANXHGTPQOBST-UHFFFAOYSA-N 0.000 description 1
- 235000021286 stilbenes Nutrition 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 229940117986 sulfobetaine Drugs 0.000 description 1
- 150000003460 sulfonic acids Chemical class 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 229910021653 sulphate ion Inorganic materials 0.000 description 1
- 239000002600 sunflower oil Substances 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 239000003760 tallow Substances 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 125000003396 thiol group Chemical group [H]S* 0.000 description 1
- 239000001585 thymus vulgaris Substances 0.000 description 1
- BJBUEDPLEOHJGE-IMJSIDKUSA-N trans-3-hydroxy-L-proline Chemical compound O[C@H]1CC[NH2+][C@@H]1C([O-])=O BJBUEDPLEOHJGE-IMJSIDKUSA-N 0.000 description 1
- WBYWAXJHAXSJNI-VOTSOKGWSA-M trans-cinnamate Chemical compound [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 229960003732 tyramine Drugs 0.000 description 1
- DZGWFCGJZKJUFP-UHFFFAOYSA-N tyramine Chemical compound NCCC1=CC=C(O)C=C1 DZGWFCGJZKJUFP-UHFFFAOYSA-N 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 229920003169 water-soluble polymer Polymers 0.000 description 1
- 239000010497 wheat germ oil Substances 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 229940118846 witch hazel Drugs 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4172—Imidazole-alkanecarboxylic acids, e.g. histidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/401—Proline; Derivatives thereof, e.g. captopril
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/10—Washing or bathing preparations
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Dermatology (AREA)
- Birds (AREA)
- Cosmetics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Description
508247 A7 _B1 五、發明説明(I ) 發明領域 本發明偽關於對皮虜施用之外用製劑,其含有一種cr-胺基酸衍生物作為活性成份,且更詳言之僳關於一種用 於增強皮虜之胞橋小體降解或角質層落屑之此等製劑。 本發明主要像用在美容及皮慮科學領域。 先前技術說明 先前研究業已顯示致濕劑對於乾燥皮虜很有效〔見, 例如,Tatsuya Ozawa 等,"The role of hunectants in skin moisture retention", Hifu(SKIN Research) ,2 7 , 2 7 6 - 2 8 8 ( 1 9 8 5 )〕。然而,致濕劑改善落屑(其為 乾燥皮虜之特徽)之機制並未充分了解。但是,各種致 濕劑已實際用於美容用製劑以施用於皮虜且業已確定其 可産生特定效果。 此等致濕劑或濕潤劑廣泛使用之典型實例為乳酸,其 屬羥基羧酸之範醻。亦已知除了前述乳酸傺屬《-經 基羧酸範圍以外,具有較甲基更長之長鏈烷基之翔 基羧酸以及亦具有羧取代基之cr-羥基羧酸(如,檸樣酸 及酒石酸)可特別併用於具有軟化角質層效果= 經滴部中央標準局員工消費合作社印製 (請先閱讀背面之注意事項再填寫本頁) 製劑(日本專利特開案Νο·8007/,83)。更者,使用2_(或 « 羥基羧酸或相關化合物於用以減輕老化 之組成物乃為已知(日本特開案Νο·139947/,93)。再者 ,亦已提供一種用以治療乾燥皮膚之組成物,其含 殊羥基羧酸或酮基羧酸或其酯及一種脂質成份如酵 氨醇(日本特開案Νο·157283/’94)。 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 508247 經滴部中央標準局員工消费合作社印製 A7 B7 五、發明説明(> ) 日本特開案Νο·8ϋ07/,83建議《 -羥基羧酸對皮膚具軟 化效果,因為其可改善角質層板之彈性模層(elastic modulus)。另一方面,日本特開案Νο·139947/’93建議 2Μ或ct -)羥基羧酸具有減少角質層内角質細胞 (corneocyte)集結之作用,但其對於角質層的外層不具 效用。更者,日本特開案Νο·157283/’94建議上逑組成 物在活體效能測試中可對乾燥皮虜帶來目視可知之改善。 此外,一般已相信脂質參與角質層(或角質化細胞之 層狀結構)之黏附。然而,基於電子顯微鏡所得資訊, 近來已建議胞橋小體為角質層細胞黏附之内在結構(見 例如 kitagima 文件(Journal of Japanese Cosaetic Science Soriety,V o 1 . 15, No· 4(1991),P P. 2 2 5 - 2 3 0〕。更者,於前述文件中,Kitaj in a亦已提出推測 胞橋小體被蛋白酶消化為角質層落屑之重要原因。更者 ,A. Lundstroea等已建議具有分子量25kDa之類糜蛋白 酶,其存在於角質層内,在活體條件下對於落屑作用扮 演一定之角色〔Acta Derm Venereol (Stockh), 1991: 71: 471-474] 〇 另一方面,本案發明者對於角質層落屑曾作研究且因 而顯示除了前述類糜蛋白酶以外,一種分子量約30fcDa 之類胰蛋白酶亦以固有蛋白酶存在,其可能涉及落暦 〔Arch· Denatol . Res . ( 1 9 9 4 ) , 2 8 6 : 2 4 9 - 2 5 3〕〇 更 者,其亦顯示致濕劑可藉由控制皮虜内特別是胞橋小體 前述兩種酶展現活性所霈部位(亦邸水性琛境)來維持健 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) (請先閲讀背面之注意事項再填寫本頁)
508247 經滴部中央標率局員工消费合作社印掣 A7 B7 五、發明説明㈠) 康的皮廣〔見,例如,F R A G R A N C E J 0 ϋ R N A L ( 1 9 9 5 ),1 3- U〕。 為了令不僅具乾性皮虜患者之皮虜,亦令正常値體之 皮膚維持健康且美麗的外表,由死表皮細胞所衍生的角 質化細_所構成之角質層之形成藉由生理性落屑來輿其 脫落保持調和乃為必需者。 必然地,如前述般,致濕劑參與角質層落屑且對維持 健康皮瞄扮演一定的角色。然而,對於顯示前述兩類型 酶活性降低現象之個體,僅藉由致濕劑之肋來控制展現 此等活性之璟境不太可能達到足夠地角質層落屑作用。 據此,本發明之目檫偽在提供一種製劑,其不僅提供 保持濕度之目的,亦更積極地增強前述兩類型酶本身之 活性。 發明槪要 本發明現已發現角質層落履偽透遇前述酶於角質層内 分解蛋白質(至少desnoglein)來達成。此一角質層落屑 之機制形成與前逑日本特開案Νο.139947/·93)所逑化合 物之機制相反,於該專利案中此等效果並不依賴對角質 層外層之作用·,且故而為完全新穎之資訊。 更者,本案發明者亦發現胞橋小體之降解可由cr-胺 基羧酸增強,該胺基酸並非必需具有自由羥基,亦即為 具有羧基及胺基依附在相同硪原子之化合物具有強化在 角質層内desaioglein之分解之效果,故而維持皮虜具有 本紙張尺度適用中國國家標準(CNS ) Λ4規格(210Χ297公釐) (請先閱讀背面之注意事項再填寫本頁)
、1T 508247 A7 B7 五、發明説明(+ ) 健康且美麗外表,及/或預防且減少皮虜無光澤現象。 附帶地,”無光澤"可定義為一種皮虜明晰度微弱的狀態。 故而,根據本發明,其提供一種用以強化皮膚胞橋小 體降解或角質層落屑作用之製劑,其包含至少一種如下 式(η之胺基酸衍生物或其鹽,或其羧酸酯作為活性 成份, 式⑴:
(請先閱讀背面之注意事項再填寫本頁) Ν-CH-GOOH ⑴ R〆 其中R1為氫原子或未取代或取代低级烷基,且於經 取代低级烷基之取代基為羥基,颡基其視需要可以低级 烷基取代,胺基其視霈要可為低级烷基取代,低级醯基 ,甲脒基1-C(=NH)-NH2),或Ν-單-或Ν,ίΓ-二(低级烷 基)脒基,苯基視需要可以羥基取代,五員雜璟其於璟中 具有一或兩個氮原子且視需要可與苯環稠合,或胺甲醯基 (-C 0 Ν Η 2 );及 經滴部中央標準局員工消費合作社印製 R2及R3各自為氫原子,低级烷基,或低级酷基;或 R2及R3之一與R1結合形成丙烷-1,3 -二基,2 -羥基 丙院-1,3 -二基或1-經基丙院-1,3 -二基。 上式(I)代表之化合物,其鹽或其羧酸酯可用以例如 減少角質層板之殘餘desnoglein之份量,以加速角質層 之更新且故而提供新鮮且年鞋的皮虜情況。據此,其可 用來作用至皮虜之外用(或表皮)製劑之活性成份,待別 用於美容或皮庸科製劑。 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) 經满部中央標準局員工消費合作社印製 508247 A 7 B7 五、發明説明(r ) 更者,本發明亦提供含有至少一種式(I)化合物之製劑 以強化皮虜角質層落屑或胞橋小體降解之用途,更者,本 發明亦提供一種保持或維持具有健康且美麗外觀之皮虜之 方法,其包含局部施用有效份量之至少一種式(1)化合物 至皮虜之步驟且故而強化皮虜之角質層落屑或胞橋小體降 解作用。 發明詳述: 在此術語"低级烷基”偽指Ci-e之直鏈或分支烷基。 未取代低级烷基之待殊例包括但不限於甲基(與丙胺酸 或其衍生物有關),乙基,丙基,異丙基(舆纈胺酸或其 衍生物有關),2-甲基丙基(與白胺酸或其衍生物有關), 1-甲基丙基(與異白胺酸或其衍生物有關),正-丁基, 正-戊基及正·己基。 R1代表之經取代低级烷基為前逑低级烷基,其中一 或多値氫原子由相同或不同取代基所取代,其將於後特 別描逑。 經取代低级烷基(其取代基為羥基)之典型實例包括羥 甲基(與絲胺酸或其衍生物有關)及1-羥基乙基(與羥丁 胺酸或其衍生物有關)。經取代低烷基其中取代基為視 需要以低级烷基取代之巯基者之典型實例包括镟基甲基 (舆半胱胺酸或其衍生物有關)及2-甲基硫乙基(與甲硫 胺酸或其衍生物有關)。 經取代低级烷基,其中取代基為一胺基其視需要由低 级烷基(較佳為甲基或乙基),低级醛基(較佳為甲醯基 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) ---------— (請先閱讀背面之注意事項再填寫本頁) 、11 508247 A7 B7 五、發明説明(& ) 或乙醯基),甲脒基(-C(=NH)-NH2),或N-單-或Ν,Ν’-二(低级烷基)-甲脒基所取代,其典型實例包括4-胺丁 基(與離胺酸或其衍生物有關)及3 -甲脒基〔或脲基( (-C(=NH)-NH2)〕-胺丙基(與精胺酸或其衍生物有關。 經取代低烷基,其中取代基為視需要由羥基取代之苯 基或者其中取代基為於環中具有一或二個氮原子且視需 要與苯環稠合之5員雜環基,其典型實例包括苯甲基( 與***酸或其衍生物有關),4 -羥苯甲基(與酪胺酸或 其衍生物有關),(1H -眯唑-4-基)甲基(與組胺酸或其衍 生物有關)及(1H-吲昤-3-基)甲基(與色胺酸或其衍生物 有關)。 更者,經取代低级烷基其中取代基為胺甲醯(-C0NH2 ) 基者,其典型實例包括胺甲醯甲基(與天冬醯胺或其衍生 物有關)及胺甲醛乙基(與麩醯胺或其衍生物有關)。 由R2及R3代表之低级烷基可為R1定義之相同低级烷 基。由R2及R3代表之低级醯基可為對應低级烷基之醯 基,如甲_基,乙醯基及丙醯基。 經滴部中央標準局員工消費合作社印^ (請先閱讀背面之注意事項再填寫本頁) 更者,R2及R3代表之醯基亦可為中等或高级醯基 。此等醋基包括衍生自C >26之脂肪酸之基。較佳地,此 等脂肪酸為衍生自然脂質者。其特殊例包括飽和脂肪酸 、衍生自米糠油,蠟,羊毛脂,椰子油,棕櫊油,乳脂 肪等,如蠟酸,廿四烷酸,山¥酸,花生酸,硬脂酸, 棕櫊酸,肉豆蔻酸,月桂酸,癸酸,辛酸,己酸及丁酸 ;及不飽和脂肪酸衍生自陸生動物脂肪(特別為牛、羊 -8 - 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) 經濟部中央標準局員工消費合作社印裝 508247 A7 B7 五、發明説明(,) 油),水生動物油(特別為魚肝油),其他蔬菜油(如芫荽 油及月見草籽油)等等,如棕櫊腦酸,嚴芹酸,油酸, 反油酸,亞油酸,y -亞油烯酸及花生四烯酸。更者, 此等脂肪酸可具羥基,如蓖麻酸及羥基亞麻酸。較 佳地,R2及R3兩者代表氫原子。 除了上述定義外,R2及R3之一可與R1結合形成形 成一個基其與相結合之氮及碩原子共同形成一値五員環 。此等基的特殊例包括丙烷-1,3-二基(-CH2 CH2 CH2 -) (與脯胺酸或其衍生物有關),2-羥丙烷-1,3-二基 (-CH2 CH(0H>CH2 -)(與4-羥基脯胺酸或其衍生物有關) 及卜羥丙烷-1,3 -二基(-CH(0H)CH2 CH2 -)(與3 -羥基脯 胺酸或其衍生物有關)。 上述化合物為透過羧基媒介(特別當R 2及R 3之一為 低級醯基時)所形成之鹽,或為透過R2 (R3 )N -基媒介 (當R2及R3為低級烷基且羧基已酯化時,亦即為羧酸 酯形式時)所形成的鹽。透過羧基媒介形成之鹽的典型例 包括銨鹽及鹼金鼷鹽如鈉、鋰及鉀鹽。透過R2 (R 3 )N-基媒介形成之鹽之典型實例包括與氫氯酸,氫溴酸,碟 酸,硫酸,有機磺酸(即,甲烷磺酸及乙烷磺酸),有機 羧酸(如乙酸,檸檬酸,馬來酸,琥珀酸且酒石酸)所形 成之鹽。 該羧酸酯可由低级至高级烷醇(如甲醇,乙醇,辛醇, 癸醇,硬脂醇或二十八烷醇)及羧基所形成。更者,當R2 及R3兩者為低级烷基(較佳為甲基)時,具有一第四鞍 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) (請先閱讀背面之注意事項再填寫本頁)
、1T 508247 經濟部中央標準局貝工消費合作社印掣 A7 B7 五、發明説明($ ) 之諸化合物,該第四銨偽藉由連結一額外低级烷基(較 佳為甲基)至該等低级烷基所依附的氮原子所形成者(與 N,N,N-三甲基-甘胺酸或其衍生物有關),亦颶於本發明 有效成份的範圍内。 於前逑諸化合物中,該等鼷於天然産生的σ-胺基酸 可特別方便地使用。然而,除了甘胺酸以外的其它的《-胺基酸,諸L-胺基酸衍生物,其諸對應異構物(D-異構 物)及其諸外消旋物亦可便利地使用。 上逑定義之式(I)化合物藉由與生理可接受之稀釋劑, 載劑,佐劑及可用於化妝品或醫藥領域的其它活性物質 相組合可以被製成不同的製劑,惟該等製劑適於本發明 的目的。典型的此等稀釋劑,載劑及佐劑包括但不限於 醫藥製劑,抗菌製劑,ΡΗ調整劑,抗氧化劑等,如脂肪 及脂肪油,包括蠟,烴油,高级脂肪酸,高级醇,矽酮 ,界面活性劑,醇,水,黏度調整劑,螯合劑,紫外線 吸收劑,致濕劑及皮虜激活劑。 油及脂肪油的實例包括亞麻籽油,山茶油,毘士蘭 果油,玉米油,貂油,橄欖油,If梨油,油茶油,蓖麻 油,紅花油,杏油,桂皮油,荷荷笆油,葡萄油,葵花 油,杏仁油,油菜籽油,芝麻油,小麥芽油,稻芽油, 稻麩油,棉籽油,大豆油,花生油,茶籽油,月見草油 ,卵黃油,牛脚油,肝油,三酸甘油酯,三辛酸干油酯 ,三異棕櫊酸甘油酯,及其它液態油及脂;椰子油,棕 櫊油,棕櫊果仁油,及其它液態或固態油及脂;可可 -10- 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) (請先閱讀背面之注意事項再填寫本頁) 麵 -一口 經濟部中央標準局員工消費合作社印4'J木 508247 A7 B7 五、發明説明(9 ) 脂,牛脂,羊脂,豬脂,馬脂,氫化油,氫化海貍油, 曰本蟠,生油樹油脂,及其它固態油及脂;蜂蠟,燭木 臘,棉臘,棕櫊臘,月桂樹臘,樹臘,鯨臘,蒙旦臘, 麩臘,羊毛脂,還原羊毛脂,硬羊毛脂,木棉臘,甘蔗 臘,荷荷Μ臘,蟲漆蠟,及其它蟠。 再者,基本上亦可能將如下成份配方至本發明製劑中 以為進一步基礎,如辛酸鯨蠟酯及其它辛酸酯,三-2-乙 基己酸甘油酯,季戊四醇四-2-乙基-己酸酯,及其它異 辛酸酯;月桂酸己酯及其它月桂酸酯,肉豆蔻酸異丙酯 ,肉豆蔻酸十八酯及其它肉豆蔻酸酯#櫊酸辛酯及其他 棕櫊酸酯;硬脂酸異鯨蠟酯及其它硬脂酸酯,異硬脂酸 異丙酯及其它異硬脂酸酯,異棕櫊酸辛基酯及其它異棕 櫊酸酯,油酸異癸酯及其它油酸酯,己二酸二異丙基酯 及其它己二酸二酯,癸二酸二乙酯及其它癸二酸二酯, 蘋果酸二異硬脂酯及其它酯油;液態石蠛,天然地蠟, 鯊烷,鯊烯,朴日斯烷,石蠘,異石蠟,地蟠,凡士林 ,徹晶蠟,及其它烴油等。 至於高级脂肪酸,例如有月桂酸,肉豆蔻酸,棕櫊酸 ,硬脂酸,山¥酸,油酸,1 2 -羥基硬脂酸,十一烷酸 ,甲苯酸,異硬脂酸,亞油酸,二十碩五烯酸(ΕΡΑ), 二十二碩六烯酸(DHA)等。 至於高級醇,例如有月桂醇,鯨蠟醇,硬脂醇,山¥醇 ,肉豆蔻醇,油醇,鯨蟠基硬脂醇及其它直鏈醇,單硬脂 基甘油W(鯊肝醇),2-decyl tetra decinol,油醇,膽固 醇,檀物固醇,十六烷醇,異硬脂醇,十八烷醇,及其它 -1 1 - 本紙張尺度適用中國國家標準(CNS ) Λ4規格(210X 297公釐) (請先閱讀背面之注意事項再填寫本頁) Φ 訂 經滴部中央標準局員工消費合作社印製 508247 A7 B7 五、發明説明(…) 分支鏈醇等。 亦可以將如下成份配方至本發明製劑中以為進一步基 礎,如二甲基聚矽氧烷,甲苯基聚矽氣烷,甲基氫聚矽 氣烷及其它鏈狀矽氣烷,八甲基環四矽氯烷,十甲基環 五矽氣烷,十二甲基環六矽氣烷,及其它環狀矽氣烷, 具有三度空間網狀結構的矽氣酮樹脂,矽酮橡膠等。 界面活性劑的實例包括皂基劑,月桂酸鈉,棕櫊酸鈉 ,及其它脂肪酸皂類,月桂磺酸鈉,月桂磺酸鉀,及其 它高级烷基磺酸酯鹽,Ρ0Ε月桂磺酸三乙醇胺,Ρ0Ε月桂 磺酸鈉,及其它烷基醚磺酸酯鹽,月桂醯基肌胺酸鈉, 及其它N-醯基肌胺酸,卜肉豆蔻基甲基牛磺酸納, N-可可基甲基牛横酸鈉(sodium N-cocoyl-N-ffiethyl taurate),月桂甲基牛磺酸鈉,及其它高级脂肪酸醯胺 磺酸鹽,Ρ0Ε油基醚磷酸鈉,Ρ0Ε硬脂酸醚磷酸酯鹽,及 其它磷酸酯鹽,二-2-乙基己基磺醯琥珀酸鈉,單月桂醯 基單乙醇醯胺多氣乙烯磺醯琥珀酸鈉,月桂基聚丙二醇 磺醯琥珀酸鈉,及其它磺醯琥珀酸鹽,線性十二烷基苯 磺酸鈉,線性十二烷基苯磺酸三乙醇胺,線性十二烷基 苯磺酸鹽,及其它烷基苯磺酸鹽,卜月桂醯基麩胺酸單 鈉,卜硬脂醯基麩胺酸二鈉,N-肉豆蔻醯基-L-麩胺酸單 鈉,及其它N-醯基麩胺酸鹽,氫化椰子油脂肪酸甘油酯 磺酸鈉及其它高級脂肪酸酯磺酸酯鹽,土耳其紅油及其 它磺酸油,Ρ0Ε烷基醚羧酸,Ρ0Ε烷芳基醚羧酸鹽,cr -烯 烴磺酸鹽,高级脂肪酸酯磺酸鹽,二级醇硫酸酯鹽,高 -1 2 - 本紙張尺度適用中國國家標率(CNS ) A4規格(210X 297公釐) (請先閱讀背面之注意事項再填寫本頁) 麵
、1T 經滴部中央標準局員工消費合作社印t 508247 A7 B7 五、發明説明(。) 级脂肪酸烷醇醯胺硫酸酯鹽,月桂醯基單乙醇醯胺琥珀 酸鈉,N-棕櫊醯基門冬胺酸酯二三乙醇醯胺,酪蛋白銷 ,及其它陰離子界面活性劑。 氯化硬脂基三甲基銨,氯化月桂基三甲基銨,及其它 烷基三甲基銨鹽,氛化二硬脂基二甲基銨,氯化二烷基 二甲基銨鹽,氯化聚-二甲基-3, 5 -亞甲基六氫毗 啶鐵),氣化鯨蠛基毗啶銷及其它烷基吼啶_鹽,烷基 四级銨鹽,烷基二甲基苯甲基銨鹽,烷基異睹啉錨鹽, 二烷基嗎啉鏘鹽,Ρ0Ε烷胺,烷胺鹽,聚胺脂肪酸衍生 物,戊醇脂肪酸衍生物,氣化苯烷_,氯化苯乙醇鐵, 及其它陽離子界面活性劑;2-十一烷基羥乙基 羧甲基)-2 -眯唑啉,2 -可可基-2-眯唑啉錨氫氣化物-1 -羧乙氣基-2-鈉鹽,及其它眯唑啉族二極性界面活性劑, 2-十七烷基羧乙基羥乙基眯唑啉錨甜菜齡,月桂 基二甲基-胺基乙酸鹽甜菜齡,烷基甜菜鹼,醯胺甜菜驗 ,磺基甜菜鹼,及其它甜菜鹼族界面活性劑,及其它二 極性界面活性劑; 山梨糖醇醉單油酸酯,山梨糖醇酐單異硬脂酸酯,山 梨糖醇酐單月桂酸酯,山梨糖醇酐單棕櫚酸酯,山梨糖 醇酐單硬脂酸酯,山梨糖醇酐一又二分之一油酸酯,山 梨糖醇酐三油酸酯,二甘油基山梨糖醇酐五辛酸酯,二 甘油基山梨糖醇酐四辛酸酯,及其它山梨糖醇酐脂肪酸 酯,甘油單棉籽油脂肪酸,甘油單芥酸酯,甘油一又二 分之一油酸酯,甘油單硬脂酸酯,甘油α 油酸鹽 -1 3- 本紙張尺度適用中國國家標準(CNS ) Α4規格(210Χ297公釐) (請先閱讀背面之注意事項再填寫本頁)
508247 A7 B7 五、發明説明(^ ) 焦谷胺酸鹽,單硬脂酸鹽甘油蘋果酸及其它甘油多甘油 脂肪酸,丙二醇單硬脂酸鹽及其它丙二醇脂肪酸酯,氫 化蓖麻油衍生物,甘油烷基醚,聚氣乙烯甲基聚矽氣烷 共聚物,及其它親液性非離子界面活性劑; Ρ0Ε山梨糖醇酐單油酸酯,Ρ0Ε山梨糖醇酐單硬脂酸酯, Ρ0Ε -山梨糖醇酐單油酸酯,Ρ0Ε -山梨糖醇酐四油酸酯, 及其它Ρ0Ε山梨糖醇酐脂肪酸酯,Ρ0Ε山梨糖醇單月桂酸 酯,Ρ0Ε -山梨糖醇單油酸酯,Ρ0Ε -山梨糖醇五油酸酯, Ρ0Ε -山梨糖醇單硬脂酸酯,及其它Ρ0Ε山梨糖醇脂肪酸 酯,Ρ0Ε-甘油單硬脂酸酯,Ρ0Ε-甘油單異硬脂酸酯, Ρ0Ε-甘油三異硬脂酸酯及其它Ρ0Ε-甘油脂肪酸酯,Ρ0Ε 單油酸酯,Ρ0Ε二硬脂酸酯,Ρ0Ε單二油酸酯,二硬脂酸 乙二醇,及其它Ρ0Ε脂肪酸酯,Ρ0Ε月桂醚,Ρ0Ε油醚, 經满部中央標準局員工消費合作社印製 (請先閱讀背面之注意事項再填寫本頁)
Ρ0Ε硬脂醚,卩0£山¥醚,Ρ0Ε 2 -十八醚,Ρ0Ε騰固醇醚 ,及其它Ρ0Ε烷基Μ, Ρ0Ε辛苯基醚,Ρ0Ε壬苯基醚,Ρ0Ε 二壬苯基醚,及其它Ρ0Ε烷苯基醚,普廉蘭尼克及其他 pluaronics, POE· POP綜撤酸,POE· P0P-2 -癸基十四 基醚,POE· POP單丁基醚,POE· POP氫化羊毛脂,Ρ0Ε • POP甘油醚,及其它Ρ0Ε-Ρ0Ρ烷基醚,秀酮酸及其它四 - Ρ0Ε·四- POP乙二胺縮合産物,Ρ0Ε蓖麻油,Ρ0Ε氫化蓖 麻油,Ρ0Ε氫化蓖麻油單異硬脂酸酯,Ρ0Ε氫化蓖麻油三 異硬脂酸酯,Ρ0Ε氫化蓖麻油單焦麩胺酸單異硬脂酸二酯 ,P 〇 E氫化蓖麻油馬來酸及其它P 0 E蓖麻油氫化蓖麻油衍生 物,Ρ0Ε山梨糖醇蠘蠟及其它Ρ0Ε蜂蠟羊毛脂衍生物,椰子 油脂肪酸二乙醇醯胺,月桂酸單乙醇醯胺,脂肪酸異丙醇 -1 4 - 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) 經滴部中央標準局員工消費合作社印裝 508247 A7 B7 五、發明説明(〇 ) 醯胺,及其它烷醇醯桉,POE丙二醇脂肪酸酯,POE烷胺 ,Ρ0Ε脂肪酸醯胺,蔗糖脂肪酸酯,Ρ0Ε壬苯基甲醛縮合 産物,院基乙氣二甲基胺氧化物,三油基磷酸,及其它 親水性非離子界面活性劑及其它界面活性劑。 醇的實例包括甲醇,乙醇,丙醇,異丙醇,及其它低 级醇,瞻固醇,胞固醇(cytosterols),植固醇,羊毛 固醇,及其它固醇等。 黏度調整劑的實例包括***膠,黃耆膠,半乳聚糖 ,槐樹豆膠,洋菜膠,剌梧桐膠,鹿角_,果膠,洋菜 ,溫桴,種籽,藻膠體(藻萃取物),澱粉(米,玉米,馬 鈐薯,小麥),及其它植物型聚合物,葡聚耱,琥珀葡 聚糖,pulleran,及其它微生物型聚合物,羧甲基澱粉 ,甲基羥丙基澱粉,及其它澱粉型聚合物,骨原膠,酪 蛋白,白蛋白,明膠,及其它動物型聚合物,甲基纖維 素,硝基纖維素,乙基纖維素,甲基羥丙基纖維素,羥 乙基纖維素,硫酸纖維素鈉,羥丙基繼維素,羧甲基纖 維素鈉,結晶纖維素鈉,纖維素粉末,及其它纖維素 型聚合物,藻酸鈉,藻酸丙二醇酯及其它藻酸型聚合物 ,聚乙烯甲基醚,羧乙烯聚合物(CARB0P0L等),及其它 乙烯型聚合物,聚氣乙烯型聚合物,聚氣乙烯-聚氧丙 烯共聚物型聚合物,聚丙烯酸鈉,聚乙基丙烯酸鹽,聚 丙烯基醯胺,及其它丙烯基型聚合物,聚乙嫌醯亞胺, 陽離子聚合物,皂土,矽酸鎂鋁,laponite,水輝石, 無水矽酸,及其它無機型水溶聚合物等。 -1 5- 本紙張尺度適用中國國家標準(CNS ) 格(210X297公釐) (請先閱讀背面之注意事項再填寫本頁)
經漓部中央標準局員工消費合作社印繁 508247 A7 B7 五、發明説明(4 ) 螯合劑的實例包括檸蘋酸,瓊脂酸,甘油酸,乳糖醛 酸,二羥基延胡索酸,奎寧酸,半乳糖二酸(galactaric acid),葡萄糖二酸,莽草酸,抗壞血酸,日檜醇, ginkgolic acid,尿黑酸,原兒茶酸,五倍子酸,單寧 酸,咖啡酸,抉康酸,龍膽酸,《-卡因酸,乙二胺四 乙酸,1,2-雙(2-胺苯氣基)乙烷- N,N,N、tT-四乙酸, 乙二醇二胺四乙酸,二乙烯三胺五乙酸,乳清酸,N-(2-羥乙基)乙二胺三乙酸,α-甘油磷酸,)g-甘油磷酸, 植酸,苯偏三酸,磷酸,多磷酸及偏磷酸,及官能性類 似上者之化合物,及,若適當,上述化合物之鹼金羼鹽 及羧酸酯。 UV吸收劑之實例包括對胺基苯甲酸及其他苯甲酸型UV 吸收劑,胺茴酸甲酯及其他胺茴酸型UV吸收劑,水揚酸 辛酯,水楊酸苯酯,水楊酸高甲酯(h〇ffl〇Kethyl salicylate),及其他水楊酸型UV吸收劑,對甲氣基肉 桂酸異丙酯,對甲氣基肉桂酸辛酯,對甲氧基肉桂酸2-乙基己酯,單-2-乙基己酸二-對-甲氣基肉桂酸甘油酯 ,〔4-雙(三甲基甲矽烷氧基 > 甲矽烷基-3-甲基丁基〕 -3,4,5-三甲氣肉桂酸酯及其他肉桂酸-型UV吸收劑,2, 4-二羥基二苯基酮,2-羥基-4-甲氣基二苯基2-羥基 - 4 -甲氣基-二苯基酮-5-橫酸,2 -翔基-4-甲氣二苯基酮 - 5-磺酸納,及其他二苯基_型1^吸收劑,尿犬酸,尿 犬酸乙酯,2-苯基-5-甲基苯並鸣唑,2-(2^羥基_5’_ 甲苯基)苯並***,4 -第三丁基- 4’-甲氣基苯甲酵基甲 -16- 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) (請先閱讀背面之注意事項再填寫本頁) 、\呑 508247 A 7 B7 五、發明説明(< ) 院等。 致濕劑的實例包括聚乙二醇,丙二醇,二丙二醇,1, 3-丁二醇,己二醇,甘油,二甘油,木糖醇,麥芽糖醇 ,麥芽糖,D-甘露糖醇,糖化澱粉,葡萄糖,果糖,乳 糖,樓硫酸軟骨素鈉,玻璃酸鈉,磷酸腺W納,乳酸納 ,掊酸,磺酸毗咯啶酮,葡萄胺,環糊精,等。 經滴部中央標準局員工消費合作社印製 (請先閱讀背面之注意事項再填寫本頁) 醫藥成份的實例包括維生素A油,視醇,棕櫊酸視醇 ,肌醇,毗眵醇chloratel,菸齡酸苄醇,菸鹼醛胺,菘 鹼酸二生育_,抗壞血基磷酸鎂,維生素02 (麥角 股化醇),二-ct-生育醇,二生育醇-2-L-抗壞血酸 鉀二酯,乙酸二生育酯,泛酸,生物素,及其它維 生素,***,乙炔基***,及其它激素,尿囊素, 甘菊環,甘草酸,及其它抗發炎劑,熊果甘,及其它美 白劑,氣化鋅,單寧酸,及其它收斂劑,L-薄荷醇,樟 腦,及其它清新劑,或硫,氯化胞溶酶,氣酸吡哆醇, 維生素Bi,等。再者,可能配方具有不同醫藥效能 之不同類型之萃取物,例如心形蕺菜萃取物,Phellon dendron aiaurense Rupr萃取物,草木橋萃取物,白死 奪麻萃取物,甘草根萃取物,草本勺藥萃取物,肥皂 草萃取物,絲瓜萃取物,金雞納樹萃取物,匍匐虎耳草 萃取物,狹菜槐萃取物,睡蓮萃取物,小茴香萃取物, 櫻草萃取物,玫瑰萃取物,地黃萃取物,檸檬萃取物, 柴草萃取物,蘆薈萃取物,鳶尾根莖萃取物,eucayptus 萃取物f間荊萃取物,鼠尾草萃取物,百里香萃取物,茶 萃取物,海草萃取物,黃瓜萃取物,珠芽萃取物,覆盆 子萃取物,滇荊芥萃取物,胡蘿S萃取物,歐洲七茱樹 -Ηϊ-- 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) 508247 A7 B7 五、發明説明(* ) 萃取物,梨萃取物,梨藥萃取物,桑椹萃取物,玉米萃 取物,金縷梅萃取物,胎座萃取物,麝春草萃取物,絲 萃取物等等。 殺菌劑的實例包括苯甲酸,水楊酸,石炭酸,山梨酸 ,對氣苯甲酸酯,對氛偏甲酚,六氛苯酚,氣化苯烷親 ,氣化chlorohexidine,三氣磺醯替苯胺,感光元素, 苯氣乙醇。 再者,本發明的製劑可包含2-胺基-2-甲基-1-丙醇, 2-胺基-2 -甲基-1,3 -丙二醇,氫氣化鉀,氫氣化鈉,三 乙醇胺,碩酸鈉,及其它中和劑;乳酸,檸樣酸,乙醇 酸,琥珀酸,酒石酸,二-蘋果酸,磺酸鉀,碩酸氫鈉, 磺酸氫銨及其它PH調整劑;抗壞血酸,生育醇,二丁 基羥基甲苯,丁基羥基苯甲醚,及其它抗氣化劑;及防 腐劑如對羥基苯甲酸甲酯,對羥基苯甲酸乙酯及對羥基 苯甲酸丁酯。 進一步,若霈要,亦可以在本發明製劑中配方適當的 粉末成份,香料,色料等,其份量不至損害本發明所欲 的效果。 經滴部中决標準局員工消费合作社印製 (請先閱讀背面之注意事項再填寫本頁) 在此,如上成份均作列示用。可被配方到本發明製劑 的成份不限於此等成份。 此等成份可於任何配方依所欲形式且以適當組合來被 配方至本發明製劑中。 本發明之配方,其藉由將上述有效成份組合稀釋劑, 載劑等,可以翳藥,類藥物(軟膏等)及化妝品的形式〔 臉部清潔劑,乳液,乳霜,凝膠,香水(beauty liquid) ,小包,面膜或其它基礎化妝品:粉底,唇蕾或其它化 -- 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) 508247 A7 B7 五、發明説明() 妝品;芳香化妝品及體美容用品〕來廣泛使用。 本發明製劑可有廣泛性質及類型,例如水溶液条統, 溶解化条統,乳化条統,粉末条統,油液条統,凝膠条 統,軟音条統,氣霧劑条統,水-油兩層条統,水-油-粉末三層糸統等。 在作為施用於皮虜的外用製劑或強化皮虜角質層落屑或 胞橋小體降解的製劑時,根據本發明,式(I)化合物可 以0·0卜2 0重量%的份量,視化合物的性質及生理活性 來使用。此等製劑主要以直接施加在皮慮上來使用,且 式(I)化合物的劑量可依治療個體的年齡及皮虜出現症 狀的駸重性來適當的控制。 故而,本發明的製劑可以預防或治療皮虜的病態性增 厚。更者,於正常個體中,其可藉由生理性落屑令其覆 蓋的角質層均勻形成且故而維持鮮嫩年~輕的皮虜狀態。 本發明參考如下待定實例更完整的解釋。 評估方法(於角質層殘餘desaogleiri的比例) 經滴部中央標準局員工消費合作社印裝 (請先閱讀背面之注意事項再填寫本頁) 本評估方法偽作為評估藉由類胰蛋白酶及類糜蛋白酶 來於角質層分解desmoglein的程度,亦即角質層落屑的 程度。低比率的殘餘desBioglein顯示前逑酶的活性被較 強地加強。 角質層自健康個體剝離且浸泡於抗腐及殺真菌劑溶液 (含60/il/ffil的康納徽素及0.5% HaN3)達30秒鐘。稱 重2b g的角質層兩面以5# 1之含5%如下表1测試化合物 的水溶液來塗附。以不含測試化合物的水溶液塗附之角 -19- 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 508247 A 7 B7 五、發明説明(J ) 質層視為對照組,該等角質層被進行如下過程。 於上述方式中所製得的角質層所放置的條件使得該角 質層具有不大於30%的濕度量(於該濕度下胞橋小體的降 解不充份),且容允於37 °C下靜置一週。此後,使用含 9M尿,2% SDS及1%氫硫基乙醇之0.1M的催斯(Tris)緩 衝液(PH9),將各個角質層於37 °C下萃取15小時。而後 ,將用於SDS-P AGE的0.7ml的樣本緩衝液(一種兩倍濃度 的Laemaili溶液)加至所生的萃取液中且加熱15分鐘。取 出1 0 # 1的此溶液且於具7 . 5 %濃度的凝膠内電泳。於電 泳後,諸蛋白質被轉移到PVDF膜上也以抗- desmoglein 抗體及鹼性磷酸酶標記的第二(抗小鼠Ig)抗體來免疫染 色。而後,此經標記的蛋白質以NBT/ BC IP基板而得以目 視得見。而後,所欲蛋白質的量被測定。此等結果以三 種測量值的平均來表示且總結於如下表I。 (請先閱讀背面之注意事項再填寫本頁) 、11
經滴部中央標準局員工消費合作社印製 -20- 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 508247
五、發明說明(/,) 表I A7 B7 - 修正 衣年月曰 補充 90, 6. -8 測試化合物 剩餘desmoglein的比率 對照組 100.00 甘胺酸 84.13 DL-丙胺酸 54.55 DL-絲胺酸 69.44 L-絲胺酸 58.41 DL-酥胺基 97.50 L-酥胺基 90.91 4-羥基-L-脯胺酸 83.04 N,N,N-三甲基甘胺酸 86.08 N-十二烷醯基甘胺酸鉀鹽 78.58 (請先閱讀背面之注意事項再填寫本頁) 經濟部智慧財產局員工消費合作社印製 重量% 而後,如上評估方法被重覆,惟前述5 %之各測試化 合物的水溶液以經調整含0.1%L -丙胺酸及2.9%N,N,N-二甲基甘胺酸的水溶液來取代。結果,殘餘desmoglein 的比率爲65.4%。 製備例1 :古龍水 (配方) 成份 1,3-丁二醇 甘油 -21- 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) 508247 A7 B7 五、發明説明( 油醇 0.1 Ρ0Ε (20)山梨耱醇酐單月桂酸酯 0.5 Ρ0ίίΠ5)月桂醇醚 0.5 乙醇 1〇.〇 DL_丙胺酸 10.0 純水 6 8 · 9 (製備方法) 將1,3 - 丁二醇及甘油於室溫下溶於純水中以形成一水 相。將其它成份溶於乙醇中且所生溶液與如上水相相混 合夾溶解此等成份。而後,所生混合物經過濾且包裹以 獲得古龍水。 製備例_2 古龍水 (配方) 成」分______ 重量1- 經濟部中央標準局員工消費合作社印製 1 , 3-丁二醇 甘油 油醇 Ρ0Ε (20)山梨耱醇酐單月桂酸酯 P 0 E (1 5 )月桂醇醚 乙醇 L -絲胺酸 純水 (製備方法) 10 77 將〗,3 -丁二醇及甘油於室溫下溶於純水中以形成一水 -22- (請先閱讀背面之注意事項再填寫本頁)
本紙張尺度適用中國國家標準(<:'^8)/\4規格(210/ 297公釐) 508247 經濟部中央標準局員工消費合作社印製 A7 B7五、發明説明(d ) 相。將其它成份溶於乙醇中且所生溶液與如上水相相混 合夾溶解此等成份。而後,所生混合物經過濾且包裹以 獲得古龍水。 製備例„3 : _古龍水 (配方) 成j分_______ 重量…QA— 1 , 3-丁二醇 6.0 甘油 4.0 油醇 0.1 Ρ0Ε (20)山梨糖醇酐單月桂酸酯 0.5 P 0 E (1 5 )月桂醇醚 乙醇 D L -絲胺酸 Ν,Ν,Ν-三甲基甘胺酸 純水 (製備方法) 將1,3 -丁二醇及甘油於室溫下溶於純水中以形成一水 相。將其它成份溶於乙醇中且所生溶液與如上水相相混 合來溶解此等成份。而後,所生混合物經過濾且包裹以 獲得古龍水。 請先閱讀背面之注意事項再填寫本頁 ,0 0 . 5 10.0 0.1 0 . 5 78,3 本紙張尺度適用中國國家標準(CNS ) Α4規格(210X297公釐) 508247 A1 B7 五、發明説明( 製Jt例j丄古龍水 (配方) 成j分________________ 1,3 - T 二醇 甘油 油醇 Ρ0Ε (20)山梨耱醇酐單月桂酸酯 P 0 E (1 5 )月桂醇醚 乙醇 DL-丙胺酸 重最% 4,0 10 (請先閱讀背面之注意事項再填寫本頁 Φ L -絲胺酸 1 純水 77 (製備方法) 將1,3 - 丁二醇及甘油於室溫下溶於純水中以形成一水 相。將其它成份溶於乙醇中且所生溶液與如上水相相混 合來溶解此等成份。而後,所生混合物經過濾且包裹以 獲得古龍水。 製ϋΐ ϋ乳霜 (配方) 成」^_______ &量1- (1 )硬脂醇 6.0 (2 )硬脂酸 2.0 (3 )氫化羊毛脂 4.0 (4)角鯊烷 9.0 24- 本紙張尺度適用中國國家標準(CNS ) Α4規格(210X297公釐) 、11 經濟部中央標準局員工消費合作社印製 508247 A7 B7 五、發明説明(W ) (5) 辛基十二醇 10. 0 (6) 1,3-丁二醇 6.0 (7) 聚乙二醇 1 500 4.0 (8) P0E(25)鯨蠟醇醚 3.0 (9) 單硬脂酸廿油酯 2.0 (1 0) L-絲胺酸 1.0 (1 1 )生育醇 0.1 (1 2 )純水 5 9.9 (製備方法) 將成份(6 )及(7 )加至純水(1 2 ),且所生溶液被加熱且 _整至7 0 t。成份(1 )至(5 )藉加熱熔化。成份(8 )至(1 1 ) 被加至其中目.所生混合物被調整至7010。此混合物被加 至上述水相中且以均勻攙拌機均質化以産生均勻顆粒。 所生乳液被驅氣,過濾且冷卻以獲得乳霜。 製_備_@1_6」___古龍水 (請先閱讀背面之注意事項再填寫本頁 •Φ 、1Τ (配方) 成」分— 經濟部中央標準局員工消費合作社印製 (1) 山梨醇 (2) 二丙二醇 (3 )聚乙二醇 (4 ) Ρ 0 Ε ( 2 0 )油醇醚 (5) 甲基纖維素 (6) 模槺籽 (7) 乙醇 重量% 4 . 0 10 -25 - 本紙張尺度適用中國國家標準(CNS ) Λ4規格(210Χ 297公釐) 508247 經濟部中央標準局員工消費合作私印製 Μ Β7 五、發明説明(>4 (8 )香料 適量 (9)石蠘 0,1 (1 0 )礤酸鈉 1.0 (Π ) DL-丙胺酸 5.0 Π 2 )純水 6 8.1 (製備方法) 將成份(5 )及(6 )被加至部份純水(1 2 )且攪拌以形成黏 稠溶液。成份(1) , ( 2 ) , ( 3 ) , (1 0 )及(1 1)被加至剩餘 純水(1 2 )巨於室溫下溶於其中,繼而加入上述黏稠溶液 。故而,穫得一均質水溶液。成份(9 ) , ( 4 )及(8 )被加 至乙醇(7 )且溶於其中以形成一醇条溶液。此醇条溶液被 加入且與如上水溶液混合。而後,諸成份被溶解化以獲 得古龍水。 製_^_例_1_1_„洗液 (配方) 成—份_ m (1 )硬脂酸 2.0 (2)鯨蠟醇 (3 )凡士林 (4) 角鯊烷 (5) 三-2-乙基己酸甘油酯
(6) 山梨糖醇酐單油酸酯 I (7) 二丙二醇 (8) 聚乙二醇1500 26 本紙張尺度適用中國國家標準(CNS ) Λ4規格(210X 297公釐) (請先閱讀背面之注意事項再填寫本頁)
508247 經濟部中央標準局員工消費合作社印t A7 B7五、發明説明(< ) (9)三乙醇胺 2.0 Π 0 )石蠟 1,0 (1 1 )番料 適量 (12)DL-絲胺酸 5·0 (1 3 )純水 6 9.4 (製備方法) 將成份(7 ), ( 8 ),及(9 )加至純水,且所生溶液被加 熱且調整至7 0 1C。成份(1 )至(5 )被熔化。成份(6 ) , (1 0 ) (11)至(12)被加至其中且所生混合物被調整至70C。此 油相被加至先前製備的水相中且接受初级乳化。而後, 此混合物以均勻攪拌機均質化以産生均勻顆粒。所生乳 液被驅氣,過濾且冷卻以獲得洗液。 製清潔泡沫 (配方)H__ (1 )硬脂酸 (2) 肉豆蔻酸 (3) 月桂酸 (4 )荷荷Μ油 (5 )氫氣化鉀 (6)山梨糖醇(70%溶液) (7 )甘油 (8) 1 , 3-丁二醇 (9 ) Ρ 0 Ε ( 2 0 )甘油單硬脂酸酯 -27- (請先閱讀背面之注意事項再填寫本頁 Φ 、1Τ 雷最% 12.0 14.0 15, 10 . 10 . 本紙張尺度適用中國國家標準(CNS ) Λ4規格(210Χ 297公釐) 508247 A7 五、發明説明() (10)醯基甲基牛磺酸 4.0 (Π )L -絲胺酸 0.5 Π 2 )香料 適量 Π 3 )純水 2 0.0 (製備方法) 將成份(1 )至(4 ), ( 6 )至(8 )及(1 1 )加熱熔化且保持在 7 0 t 將成份(5)溶於純水,且所生溶液以攪拌被加進 油相。於中和反應生效一足夠長的時間後,界面活性劑 (9 )及(1 0 )被加入其中,繼而加入成份(1 2 )。該反應混合 物被驅氣,過濾且冷卻以獲得清潔泡沫。 製_霞_例__9_」+洗液 (配方) 酿I_ (1 )硬脂酸 (2)鯨蠘醇 (3 )凡士林 (4) 角鯊烷 (5) 三-2-乙基己酸甘油酯 (6) 山梨耱醇酐單油酸酯 (7) 二丙二醇 (8) 聚乙二醇1500 (9) 三乙醇胺 (10) 石蟠 (1 1 )香料 本紙張尺度適用中國國家標準(CNS ) Λ4規格(210X 297公釐) (請先閱讀背面之注意事項再填寫本頁)
經濟部中央標準局員工消費合作社印製 508247 經濟部中央標準局員工消費合作社印製 五、發明説明(β ) (12) DL -絲胺酸 0·2 (13) Ν,Ν,Ν-三甲基甘胺酸 3.0 (1 4 )純水 7 1,2 (製備方法) 將成份(7 ) , ( 8 ),及(9 )加至純水,且所生溶液被加 熱目調整至7 0 t。成份(1 )至(5 )被熔化。成份(6 ) , (1 0 ) (11), (12)及(13)被加至其中且所生混合物被調整至7〇υ 。眈油相被加至先前製備的水相中且接受初級乳化。而 後,I比混合物以均勻攪拌機均質化以産生均勻顆粒。所 生乳液被驅氣,過濾且冷卻以獲得洗液。 製_備_1丄0„1_古龍水 (配方) I份__ 重ϋ— 1,3 醇 甘油 油醇 Ρ0Ε (20)山梨糖醇酐單月桂酸酯 POE (1 5)月桂醇醚 乙醇 DL -絲胺酸 Ν,Ν,Ν-三甲基甘胺酸 Ν -(2-羥乙基)乙烯 二胺三乙酸 純水 -29- 本紙張尺度適用中國國家標準(CNS ) Α4規格(210Χ29?公釐) 10 75 (請先閱讀背面之注意事項再填寫本頁)
經漓部中央標準局員工消費合作社印製 508247 A7 B7 五、發明説明(d ) (製備方法) 將1 , 3 - 丁二醇及甘油於室溫下溶於純水中以形成一水 相。將其它成份溶於乙醇中且所生溶液與如上水相相混 合來溶解此等成份。而後,所生混合物經過濾且包裹以 穫得古龍水。 製備例丄1丄_古龍水 (配方) 成— 份_____________ 重量I— 1,3 - 丁二醇 6,0 甘油 4.0 油醇 0.1 Ρ0Ε (20)山梨糖醇酐單月桂酸酯 0.5 P0E(15)月桂醇醚 乙醇 L -絲胺酸 Ν,Ν,Ν-三甲基甘胺酸 Ν- (2_羥乙基)乙烯 二胺三乙酸 純水 (製備方法) 將1 , 3 - 丁二醇及甘油於室溫下溶於純水中以形成一水 相。將其它成份溶於乙醇中且所生溶液與如上水相相混 合夾溶解此等成份。而後,所生混合物經過濾且包裹以 獲得古龍水。 本紙張尺度適用中國國家標準(CNS ) Λ4規格(210X 297公犮) (請先閱讀背面之注意事項再填寫本頁)
508247 Α7 Β7 五、發明説明(β) 製徽_微丄2丄_古龍水 (配方) 成」分__ 重i_%. 1 , 3 - 丁二醇 6.0 甘油 4.0 油醇 0,1 Ρ0Ε (20)山梨耱醇酐單月桂酸酯 0.5 P 0 E (1 5 )月桂醇醚 乙醇 i)L-丙胺酸 N -(2-羥乙基)乙烯 二胺三乙酸 純水 (製備方法) 將1 , 3 _ 丁二醇及甘油於室溫下溶於純水中以形成一水 相。將其它成份溶於乙醇中且所生溶液與如上水相相混 合來溶解此等成份。而後,所生混合物經過濾且包裹以 穫得古龍水。 製__備_例丄3 _1__古龍水 (配方) 成」分_________ 重ϋ…. 1,3_丁二醇 6.0 甘油 4.0 油醇 0.1 -31 - 本紙張尺度適用中國國家標準(〔^5)/\4規格(210/297公漦) (請先閱讀背面之注意事項再填寫本頁)
經濟部中央標準局員工消費合作社印製
成」iL 508247 Α7 Β7 五、發明説明(w ) POE (20)山梨糖醇酐單月桂酸酯 0,5 Ρ0ΕΠ5)月桂醇醚 0.5 乙醇 10.0 L -絲胺酸 0 ♦ 5 N -(2-羥乙基)乙烯 二胺三乙酸 0.2 純水 78.2 (製備方法) 將1,3 - 丁二醇及甘油於室溫下溶於純水中以形成一水 相。將其它成份溶於乙醇中且所生溶液與如上水相相混 合來溶解此等成份。而後,所生混合物經過濾且包裹以 獲得古龍水。 製_古龍水 (配方) 重量% (請先閱讀背面之注意事項再填寫本頁) 、1Τ 經濟部中央標準局員工消費合作社印製 1 , 3 - 丁二醇 甘油 油醇 Ρ0Ε (20)山梨耱醇酐單月桂酸酯 P 0 E (1 5 )月桂醇醚 乙醇 Ν , Η,N-三甲基甘胺酸 Ν -(2-羥乙基)乙烯 二胺三乙酸 6.0 10 -32 本紙張尺度適用中國國家標準(CNS ) Λ4規格(210Χ297公漦) 508247 A7 B7 五、發明説明(W ) 純水 72.9 (製備方法) 將1,3 - 丁二醇及甘油於室溫下溶於純水中以形成一水 相。將其它成份溶於乙醇中且所生溶液與如上水相相混 合來溶解此等成份。而後,所生混合物經過濾且包裹以 獲得古龍水。 製」1級_13_丄_古龍水 (配方) 成」分________________ g Μ ..96 ,3 - 丁二醇 (請先閱讀背面之注意事項再填寫本頁 ΙΦ 經濟部中央標準局員工消費合作社印製 甘油 4 油醇 0 Ρ 0 Ε ( 2 0 )山梨耱醇酐單月桂酸酯 0 Ρ0Ε (15)月桂醇醚 0 乙醇 10 L -絲胺酸 0 DL_丙胺酸 0 N -( 2 _羥乙基)乙烯 二胺三乙酸 0.2 純水 78,1 (製備方法) 將1,3 -丁二醇及甘油於室溫下溶於純水中以形成一水 相。將其它成份溶於乙醇中且所生溶液與如上水相相,混 合來溶解此等成份。而後,所生混合物經過濾且包裹以 33 - 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 、11 508247 Α7 Β7 經濟部中央標隼局員工消費合作社印製 五、發明説明(w) 糟得古龍水。 製備Λ丄6」_古龍水 (配方) 成―份_____________ 1,3 - 丁二醇 6.0 甘油 4.0 油醇 0.1 Ρ0Ε (20)山梨糖醇酐單月桂酸酯 0.5 Ρ Ο Ε Π 5 )月桂醇醚 乙醇 L -絲胺酸 DL -丙胺酸 Ν , Ν , Ν-三甲基甘胺酸 Ν- (2-羥乙基)乙烯 二胺三乙酸 純水. (製備方法) 將1 , 3 - 丁二醇及甘油於室溫下溶於純水中以形成一水 相。將其它成份溶於乙醇中且所生溶液與如上水相相混 合來溶解此等成份。而後,所生混合物經過濾且包裹以 穫得古龍水。
(請先閱讀背面之注意事項再填寫本頁) -34- 本紙張尺度適用中國國家標準(CNS ) Λ4規格(210X 297公釐)
Claims (1)
- 508247六、申請奪村範谓 第87 1 04724號「美容用或皮膚科之局部用組成物」專利案 煩請委員明示,本案修正後是石變更原t賀β容 六申請專利範圍: (91年3月6日修正) 一種美容用或皮膚科之局部用組成物,包含至少一 種如下式(I )之α -胺基酸衍生物,其可呈鹽,羧酸 酯或當R2及R3兩者爲C6院基時呈第四錢化合物的 形式,且其係以強化角質層落屑或胞橋小體降解,或 預防或減少皮膚頓無光澤所需的份量來存在;以及 一種生理可接受的稀釋劑或佐劑: R, N-CH-C00H (I) 其中R1爲氫原子或取代或未取代烷基,且於經 取代C ^ 6烷基之取代基爲一羥基;及 R2及R3各自爲一氫原子,一Ci_6院基,或一 C】_i2醯 基;或 R2及R3之一與R1結合來形成丙烷-1,3-二基,2-羥 丙1兀-1,3- 一基或1·淫丙院-1,3-二基。 _如申請專利範圍第1項之組成物,其中α -胺基酸 衍生物係選自天然發生的α -胺基酸及其外消旋物。 如申請專利範圍第1項之組成物,其中於式(I )之 R2及R3各自爲氫原子,一 Ci_6烷基或一 Ci_6醯基。 508247 六、申請專利範圍 4 .如申請專利範圍第1項之組成物,其中α -胺基酸 衍生物係一種α-胺基酸或其衍生物,選自DL-丙胺 酸,L-丙胺酸,DL-絲胺酸,L-絲胺酸、脯胺酸,4-羥基脯胺酸,,甘胺酸,Ν,Ν,Ν-三甲基甘胺酸及 Ν -十二烷醯基甘胺酸鉀鹽。
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP9438997 | 1997-03-31 | ||
JP24482797 | 1997-08-27 |
Publications (1)
Publication Number | Publication Date |
---|---|
TW508247B true TW508247B (en) | 2002-11-01 |
Family
ID=26435659
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW087104724A TW508247B (en) | 1997-03-31 | 1998-03-30 | Cosmetic or dermatological topical composition |
Country Status (5)
Country | Link |
---|---|
US (1) | US20020041889A1 (zh) |
EP (1) | EP0852949A3 (zh) |
KR (1) | KR19980080965A (zh) |
DE (1) | DE852949T1 (zh) |
TW (1) | TW508247B (zh) |
Families Citing this family (119)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7396526B1 (en) | 1998-11-12 | 2008-07-08 | Johnson & Johnson Consumer Companies, Inc. | Skin care composition |
KR20000044978A (ko) * | 1998-12-30 | 2000-07-15 | 성재갑 | 각질 박리 촉진용 조성물 |
US6242491B1 (en) | 1999-06-25 | 2001-06-05 | Rima Kaddurah-Daouk | Use of creatine or creatine compounds for skin preservation |
DE10032964B4 (de) * | 2000-07-06 | 2017-10-12 | Beiersdorf Ag | Verwendung von Kreatin in kosmetischen oder dermatologischen Zubereitungen |
US20020071818A1 (en) * | 2000-10-02 | 2002-06-13 | Cole Curtis A. | Skin cleanser containing anti-aging active |
FR2816837A1 (fr) * | 2000-11-17 | 2002-05-24 | Oreal | Utilisation d'au moins un derive amino sulfonique dans une composition destinee a favoriser la desquamation de la peau |
FR2816838B1 (fr) * | 2000-11-17 | 2004-12-03 | Oreal | Utilisation de derives de l'acide 2-oxothiazolidine- 4-carboxylique comme agents prodesquamants |
DE10148966A1 (de) * | 2001-10-04 | 2003-04-10 | Beiersdorf Ag | Betainhaltige Kosmetika |
FR2834635A1 (fr) * | 2002-01-17 | 2003-07-18 | Oreal | Utilisation de l'acide methyl glycinediacetique ou de ses derives comme desquamant |
FR2831445A1 (fr) * | 2002-02-14 | 2003-05-02 | Oreal | Composition comprenant au moins un pro-desquamant et au moins un compose activateur de la melanogenese |
EP1459736A1 (en) * | 2003-03-14 | 2004-09-22 | The Procter & Gamble Company | Skin care composition that increase and repair skin barrier function |
FR2864445B1 (fr) * | 2003-12-30 | 2006-04-28 | Jean Noel Thorel | Utilisation topique d'une base nutritive complexe |
US20050232894A1 (en) * | 2004-04-20 | 2005-10-20 | Weiner Gregory M | Antimicrobial skin treatment composition and methods for producing and using an antimicrobial skin treatment composition |
FR2871688B1 (fr) | 2004-06-16 | 2008-05-16 | Oreal | Procede pour favoriser la penetration d'un actif et composition permettant sa mise en oeuvre |
FR2874321B1 (fr) | 2004-08-17 | 2010-11-26 | Oreal | Composition topique comprenant des particules poreuses chargees et un compose absorbant le sebum |
FR2875134B1 (fr) | 2004-09-16 | 2007-08-24 | Oreal | Utilisation cosmetique d'une composition renfermant un derive ascorbique et des particules de polyamide |
US7300649B2 (en) | 2005-02-11 | 2007-11-27 | Genepharm, Inc. | Cosmetic and cosmeceutical compositions for restoration of skin barrier function |
FR2883168B1 (fr) | 2005-03-18 | 2008-01-11 | Oreal | Compositions cosmetiques de soin, renforcement et/ou reparation des substrats keratiniques comprenant des polypeptides kap |
JP4865251B2 (ja) * | 2005-05-09 | 2012-02-01 | 株式会社 資生堂 | 不全角化抑制剤、毛穴縮小剤及び皮膚外用組成物 |
FR2889808B1 (fr) | 2005-08-17 | 2011-07-22 | Oreal | Utilisation de l'acide 8-hexadecene-1,16-dicarboxylique comme agent de soin destine a favoriser la cohesion de la couche cornee |
FR2902999B1 (fr) | 2006-07-03 | 2012-09-28 | Oreal | Utilisation de derives c-glycoside a titre d'actif prodesquamant |
FR2909552B1 (fr) | 2006-12-12 | 2009-11-20 | Oreal | Utilisation cosmetique de l'acide anisique pour favoriser la desquamation |
FR2912917B1 (fr) | 2007-02-26 | 2012-05-18 | Oreal | Milieu conditionne et ses utilisations |
US20080227747A1 (en) * | 2007-03-15 | 2008-09-18 | Tabbiner Philip | Composition and methods for treating or preventing degenerative joint and cardiovascular conditions |
FR2914189A1 (fr) | 2007-03-26 | 2008-10-03 | Oreal | Utilisation d'une fraction lipopolysaccharidique de vitreoscilla filiformis comme agent stimulant la synthese de peptides antimicrobiens de la peau. |
FR2918269B1 (fr) | 2007-07-06 | 2016-11-25 | Oreal | Composition de protection solaire contenant l'association d'un polymere semi-cristallin et de particules de latex creuses. |
FR2918561B1 (fr) | 2007-07-09 | 2009-10-09 | Oreal | Utilisation pour la coloration de la peau de l'acide dehydroascorbique ou des derives polymeres ; procedes de soin et/ou de maquillage. |
FR2918563B1 (fr) | 2007-07-12 | 2009-12-04 | Oreal | Composition photoprotectrice fluide aqueuse a base d'un polymere polyamide a terminaison amide tertiaire. |
FR2918886B1 (fr) | 2007-07-17 | 2010-01-08 | Oreal | Utilisation d'au moins un extrait bacterien cultive sur eau thermale pour le traitement des peaux, muqueuses et cuirs chevelus sensibles |
FR2918883B1 (fr) | 2007-07-17 | 2010-01-15 | Oreal | Utilisation d'un extrait bacterien cultive sur une eau thermale pour le traitement des peaux seches |
FR2920304B1 (fr) | 2007-09-04 | 2010-06-25 | Oreal | Utilisation cosmetique de lysat bifidobacterium species pour le traitement de la secheresse. |
FR2920305B1 (fr) | 2007-09-04 | 2010-07-30 | Oreal | Utilisation d'un lysat de bifidobacterium species pour le traitement de peaux sensibles. |
FR2931064B1 (fr) | 2008-05-14 | 2010-08-13 | Oreal | Composition cosmetique contenant un derive de dibenzoylmethane et un derive de pyrrolidinone; procede de photostabilisation du derive de dibenzoylmethane |
FR2936706B1 (fr) | 2008-10-08 | 2010-12-17 | Oreal | Composition cosmetique contenant un derive de dibenzoylmethane et un compose dithiolane ; procede de photostabilisation du derive de dibenzoylmethane |
FR2937547B1 (fr) | 2008-10-28 | 2012-11-09 | Oreal | Utilisation d'un lysat de microorganisme pour le traitement des peaux grasses |
FR2939042B1 (fr) | 2008-11-28 | 2010-11-26 | Oreal | PROCEDE DE DEPIGMENTATION DES MATIERES KERATINIQUES A l'AIDE DE COMPOSES DITHIOLANNES. |
FR2939036B1 (fr) | 2008-12-01 | 2010-12-17 | Oreal | Procede de coloration artificielle de la peau utilisant un melange de carotenoide et de colorant vert lidophile ; nouveau melange de colorants lipophiles ; composition |
FR2942719B1 (fr) | 2009-03-04 | 2011-08-19 | Oreal | Utilisation de microorganismes probiotiques pour limiter les irritations cutanees |
WO2011010075A1 (fr) | 2009-07-24 | 2011-01-27 | L'oreal | Utilisation d'un derive d'acide jasmonique en tant qu'agent apaisant |
FR2954140A1 (fr) | 2009-12-17 | 2011-06-24 | Oreal | Compositions cosmetiques ou dermatologiques a base de bacteriocines et de prebiotiques |
BR112012014715A2 (pt) | 2009-12-18 | 2018-10-09 | Oreal | "processo de tratamento cosmético da pele, e, conjunto cosmético" |
FR2956582B1 (fr) | 2010-02-19 | 2012-08-24 | Oreal | Composition sous forme de poudre comprenant au moins une charge, au moins une huile essentielle et au moins un ester hydroxyle de polyol et d'acide(s) carboxylique(s) en c4 a c16 |
FR2960773B1 (fr) | 2010-06-03 | 2015-12-11 | Oreal | Procedes de traitement cosmetique utilisant un revetement a base d'un polymere polyamide-polyether |
FR2968569B1 (fr) | 2010-12-13 | 2013-01-04 | Oreal | Procede de traitement de la peau grasse non acneique. |
FR2968661B1 (fr) | 2010-12-14 | 2016-01-01 | Oreal | Procede de depigmentation des matieres keratiniques a l'aide de composes thiopyridinones |
FR2969149B1 (fr) | 2010-12-16 | 2012-12-28 | Oreal | Procede de depigmentation des matieres keratiniques a l' aide de composes derives de resorcinol |
FR2968952A1 (fr) | 2010-12-17 | 2012-06-22 | Oreal | Ester d'acide amine n-acyle a titre d'agent apaisant |
GR20110100075A (el) * | 2011-02-11 | 2012-09-20 | Ιφιγενεια Δημητριου Σιγαλα-Χαραλαμπιδου | Μεθοδος παρασκευης και συνθεση κρεμας πιλινγκ προσωπου |
FR2973237A1 (fr) | 2011-03-31 | 2012-10-05 | Oreal | Procede de traitement cosmetique fractionne utilisant un laser ou des micro-aiguilles |
JP2014524901A (ja) | 2011-06-13 | 2014-09-25 | ザ プロクター アンド ギャンブル カンパニー | ジアミドゲル化剤を含むパーソナルケア組成物及び使用方法 |
WO2012174091A2 (en) | 2011-06-13 | 2012-12-20 | The Procter & Gamble Company | PERSONAL CARE COMPOSITIONS COMPRISING A pH TUNEABLE GELLANT AND METHODS OF USING |
US9675531B2 (en) | 2011-06-20 | 2017-06-13 | The Procter & Gamble Company | Personal care compositions comprising shaped abrasive particles |
FR2981272A1 (fr) | 2011-10-14 | 2013-04-19 | Inneov Lab | Utilisation d'une composition orale comprenant un melange d'au moins un polyphenol, de zinc, et de vitamine c. |
FR2984128A1 (fr) | 2011-12-14 | 2013-06-21 | Oreal | Utilisation de la proteine mmp-12 dans la prevention et/ou le traitement des peaux sensibles. |
FR2984127A1 (fr) | 2011-12-14 | 2013-06-21 | Oreal | Utilisation de la proteine mmp-12 dans la prevention et/ou le traitement des peaux grasses et/ou a tendance grasse. |
FR2984130A1 (fr) | 2011-12-14 | 2013-06-21 | Oreal | Utilisation de la proteine mmp-12 dans la prevention et/ou le traitement des peaux vieillies ou senescentes. |
US9271912B2 (en) | 2012-06-13 | 2016-03-01 | The Procter & Gamble Company | Personal care compositions comprising a pH tuneable gellant and methods of using |
FR2991984B1 (fr) | 2012-06-19 | 2014-07-11 | Oreal | Nouveaux derives de resorcinol et leur application cosmetique |
FR2991986B1 (fr) | 2012-06-19 | 2015-02-27 | Oreal | Nouveaux derives de resorcinol et leurs applications cosmetiques |
FR2991985B1 (fr) | 2012-06-19 | 2019-11-08 | L'oreal | Procede de depigmentation des matieres keratiniques a l'aide de nouveaux composes derives de resorcinol |
FR2992183B1 (fr) | 2012-06-21 | 2015-04-10 | Oreal | Composition a effet matifiant comprenant des particules d'aerogels hydrophobes et des particules de polymeres expanses |
FR2992185B1 (fr) | 2012-06-21 | 2015-03-27 | Oreal | Composition a effet matifiant comprenant des particules d'aerogels hydrophobes et des particules de silice |
FR2992210B1 (fr) | 2012-06-21 | 2014-11-28 | Oreal | Composition a effet matifiant comprenant des particules d'aerogels hydrophobes et des particules d'elastomeres de silicone |
FR2992182B1 (fr) | 2012-06-21 | 2014-06-20 | Oreal | Composition a effet matifiant comprenant des particules d'aerogels hydrophobes et des particules de perlite |
FR2992200B1 (fr) | 2012-06-21 | 2014-11-28 | Oreal | Composition a effet matifiant comprenant des particules d'aerogels hydrophobes et un ether de polyol et de polyalkyleneglycols |
FR2992184B1 (fr) | 2012-06-21 | 2015-03-27 | Oreal | Composition a effet matifiant comprenant des particules d'aerogels hydrophobes et un amidon |
FR2992188B1 (fr) | 2012-06-21 | 2014-11-28 | Oreal | Composition a effet matifiant comprenant des particules d'aerogels hydrophobes et un tensioactif non ionique oxyethylene |
FR3000670B1 (fr) | 2013-01-10 | 2015-02-27 | Oreal | Composition cosmetique apaisante a base d'acide salicylique. |
US9511144B2 (en) | 2013-03-14 | 2016-12-06 | The Proctor & Gamble Company | Cosmetic compositions and methods providing enhanced penetration of skin care actives |
EP2789369B1 (en) | 2013-04-14 | 2018-06-06 | Symrise AG | A composition for lightening skin and hair |
EP2842607B1 (en) | 2013-09-02 | 2018-05-30 | Symrise AG | A skin and/or hair whitening mixture |
CN105555366B (zh) | 2013-09-22 | 2020-12-01 | 西姆莱斯股份公司 | 海马齿苋提取物及其应用 |
EP2853254B1 (en) | 2013-09-26 | 2017-11-08 | Symrise AG | A composition for lightening skin and/or hair |
EP2859883B1 (en) | 2013-10-13 | 2019-05-15 | Symrise AG | Active mixtures comprising acylated oligopeptides and troxerutin |
EP3062766A1 (en) | 2013-10-29 | 2016-09-07 | L'Oreal, S.A. | Use of mono ornithine ketoglutarate (mokg) |
EP2979682B1 (en) | 2014-07-30 | 2018-09-05 | Symrise AG | A fragrance composition |
EP3023090B1 (en) | 2014-11-21 | 2019-08-07 | Symrise AG | Compositions |
EP3045161A1 (en) | 2015-01-18 | 2016-07-20 | Symrise AG | Active compositions comprising 1,2-hexanediol and 1,2-octanediol |
PL3081207T3 (pl) | 2015-04-16 | 2023-03-20 | Symrise Ag | Zastosowanie kompozycji liposomowej |
WO2016174011A1 (en) | 2015-04-28 | 2016-11-03 | Cutech Srl | Compositions comprising valerian extracts |
EP3097905B1 (en) | 2015-05-28 | 2020-11-04 | Symrise AG | Cosmetic compositions |
EP3108941B1 (en) | 2015-06-23 | 2018-05-09 | Symrise AG | Compositions comprising polyalkylene glycol derivatives |
WO2017071752A1 (en) | 2015-10-28 | 2017-05-04 | Symrise Ag | Method for inhibiting or masking fishy odours |
JP6784760B2 (ja) | 2015-11-15 | 2020-11-11 | シムライズ アーゲー | 皮膚の刺痛の低減 |
WO2017097434A1 (en) | 2015-12-06 | 2017-06-15 | Symrise Ag | A fragrance composition |
FR3045604B1 (fr) | 2015-12-18 | 2018-01-26 | L'oreal | Procede de depigmentation des matieres keratiniques a l'aide de composes thiopyridinones |
EP3435969A1 (en) | 2016-03-30 | 2019-02-06 | Symrise AG | An active mixture |
EP3500236A1 (en) | 2016-08-20 | 2019-06-26 | Symrise AG | A preservative mixture |
JP7441042B2 (ja) | 2016-12-02 | 2024-02-29 | シムライズ アーゲー | 化粧品ブレンド |
IT201700090929A1 (it) | 2017-08-07 | 2019-02-07 | Cutech S R L | Usi cosmetici e medici di estratti del fungo Coprinus comatus per la regolazione dell’unità pilo sebacea. |
DE202017007679U1 (de) | 2017-08-09 | 2024-03-15 | Symrise Ag | 1,2-Alkandiole |
EP4331684A3 (en) | 2017-08-09 | 2024-05-29 | Symrise AG | 1,2-alkanediols |
CA3092158A1 (en) | 2018-03-08 | 2019-09-12 | Symrise Ag | Mixtures comprising a protein extract for the treatment of human skin and/or hair |
KR102253135B1 (ko) * | 2018-07-17 | 2021-05-17 | 주식회사 엘지생활건강 | 각질 박리 증진용 화장료 조성물 |
WO2020017760A1 (ko) * | 2018-07-17 | 2020-01-23 | 주식회사 엘지생활건강 | 각질 박리 증진용 화장료 조성물 |
CN112912051A (zh) | 2018-09-20 | 2021-06-04 | 西姆莱斯股份公司 | 包含1,2-戊二醇的组合物 |
CA3131978A1 (en) | 2019-03-12 | 2020-09-17 | Symrise Ag | An antimicrobial mixture |
FR3111546B1 (fr) | 2020-06-19 | 2023-04-07 | Oreal | Composition comprenant un polyol, un ester de polyglycérol, un sel d’acide hyaluronique et un polymère hydrophile spécifique |
WO2021255255A1 (en) | 2020-06-19 | 2021-12-23 | L'oreal | Composition comprising a polyol, a polyglycerol ester, a hyaluronic acid salt and a specific hydrophilic polymer |
WO2022122137A1 (en) | 2020-12-09 | 2022-06-16 | Symrise Ag | Compositions comprising antimicrobials and (bio)-alkanediols for skin protection |
WO2022122138A1 (en) | 2020-12-09 | 2022-06-16 | Symrise Ag | Multifunctional compound mixtures comprising multiple (bio)-alkanediols |
WO2022122136A1 (en) | 2020-12-09 | 2022-06-16 | Symrise Ag | Compositions comprising one or more (bio)-alkanediols with antioxidants |
WO2022122131A1 (en) | 2020-12-09 | 2022-06-16 | Symrise Ag | Compositions comprising lipophilic compounds and one or more (bio)-alkanediols |
WO2022122132A1 (en) | 2020-12-09 | 2022-06-16 | Symrise Ag | Compositions comprising natural polymers and one or more (bio)-alkanediols |
WO2022122133A1 (en) | 2020-12-09 | 2022-06-16 | Symrise Ag | Compositions comprising uv-filters and one or more (bio)-alkanediols |
WO2022122140A1 (en) | 2020-12-09 | 2022-06-16 | Symrise Ag | Compositions comprising one or more (bio)-alkanediols with active ingredients |
WO2022122135A1 (en) | 2020-12-09 | 2022-06-16 | Symrise Ag | Compositions comprising (bio)-alkanediols with antimicrobials for product protection |
WO2022122134A1 (en) | 2020-12-09 | 2022-06-16 | Symrise Ag | Compositions with (bio)-alkanediols and cooling agents |
FR3133014A1 (fr) | 2022-02-28 | 2023-09-01 | L'oreal | Compositions et procédés pour améliorer l’aspect de la peau |
FR3130603A1 (fr) | 2021-12-20 | 2023-06-23 | L'oreal | Composition cosmétique aqueuse avec acide ascorbique et urée |
FR3134006A1 (fr) | 2022-04-01 | 2023-10-06 | L'oreal | compositions et procédés pour améliorer l’aspect de la peau |
WO2024028512A1 (en) | 2022-08-05 | 2024-02-08 | Symrise Ag | Compositions comprising an antimicrobial boosting agent |
WO2024027931A1 (en) | 2022-08-05 | 2024-02-08 | Symrise Ag | Odor and colorant stabilized compositions |
WO2024027930A1 (en) | 2022-08-05 | 2024-02-08 | Symrise Ag | Compositions comprising an antimicrobial boosting agent |
WO2024028513A1 (en) | 2022-08-05 | 2024-02-08 | Symrise Ag | Odor and colorant stabilized compositions |
FR3142901A1 (fr) | 2022-12-09 | 2024-06-14 | L'oreal | Compositions cosmétiques avec meilleure résistance à l’usure et au transfert |
WO2024049923A1 (en) | 2022-08-31 | 2024-03-07 | L'oreal | Compositions and methods for skin |
WO2024049867A1 (en) | 2022-08-31 | 2024-03-07 | L'oreal | Cosmetic compositions with improved wear and transfer resistance |
FR3143355A1 (fr) | 2022-12-14 | 2024-06-21 | L'oreal | Compositions et procédés de prévention et/ou de traitement des cicatrices |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6130509A (ja) * | 1984-07-23 | 1986-02-12 | Shiseido Co Ltd | 皮膚外用剤 |
JPS61227515A (ja) * | 1985-04-01 | 1986-10-09 | Shiseido Co Ltd | 皮膚外用剤 |
JPS63230615A (ja) * | 1987-03-20 | 1988-09-27 | Shiseido Co Ltd | 化粧料 |
FR2627385B3 (fr) * | 1988-02-23 | 1991-08-23 | Serobiologiques Lab Sa | Composition notamment utile comme matiere de base pour la preparation de compositions pharmaceutiques, notamment dermatologiques et/ou cosmetiques |
JPH06145037A (ja) * | 1992-05-28 | 1994-05-24 | Shiseido Co Ltd | 皮膚外用剤 |
ATE215810T1 (de) * | 1994-07-01 | 2002-04-15 | Procter & Gamble | Abschuppungs-zusammensetzung |
FR2738484B1 (fr) * | 1995-09-07 | 1997-10-03 | Oreal | Utilisation de l'acide cysteique ou homocysteique pour favoriser la desquamation de la peau ou stimuler le renouvellement epidermique |
-
1998
- 1998-03-30 EP EP98105789A patent/EP0852949A3/en not_active Withdrawn
- 1998-03-30 DE DE0852949T patent/DE852949T1/de active Pending
- 1998-03-30 TW TW087104724A patent/TW508247B/zh not_active IP Right Cessation
- 1998-03-31 US US09/052,023 patent/US20020041889A1/en not_active Abandoned
- 1998-03-31 KR KR1019980011374A patent/KR19980080965A/ko not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
US20020041889A1 (en) | 2002-04-11 |
EP0852949A3 (en) | 1999-08-04 |
KR19980080965A (ko) | 1998-11-25 |
EP0852949A2 (en) | 1998-07-15 |
DE852949T1 (de) | 1998-11-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TW508247B (en) | Cosmetic or dermatological topical composition | |
US11752084B2 (en) | Methods for fat reduction or elimination of lipid droplets | |
RU2537235C2 (ru) | Мягко действующие несмываемые композиции для ухода за кожей | |
US20080254150A1 (en) | Management of dermatitic symptoms of mammalian integument with emollient disinfectant formulations | |
EP0650720A1 (en) | Skin care and deodorant compositions | |
CA2678780A1 (en) | Management of dermatitic symptoms of mammalian integument with emollient disinfectant formulations | |
JPH0657651B2 (ja) | 化粧料組成物 | |
JP3590369B2 (ja) | クリプトタンシノンを含むニキビ予防及び治療用化粧料組成物 | |
JP2002161027A (ja) | 炎症および紅斑の減少方法および組成物 | |
CA2365660A1 (en) | Treatment for skin | |
JPS6115809A (ja) | 細胞賦活剤 | |
KR101460777B1 (ko) | 여드름 개선용 화장료 조성물 | |
JP2005047910A (ja) | 皮脂分泌抑制用組成物 | |
JPH11286423A (ja) | 体臭抑制用組成物 | |
JPH11269034A (ja) | ニキビ改善用皮膚外用剤 | |
JP2003267821A (ja) | 化粧品原料 | |
WO2018012157A1 (ja) | メラニン産生抑制剤、美白剤、線維芽細胞活性化剤、コラーゲン及び/又はエラスチン産生促進剤、及びシワ改善剤 | |
JP2008308462A (ja) | 皮膚外用組成物 | |
KR101322850B1 (ko) | 박하잎 추출물, 밀싹 추출물 및 길경 추출물을 유효성분으로 포함하는 모공 축소 또는 피지분비 억제용 화장료 조성물 | |
JPH11130650A (ja) | デスモソームの分解促進剤および角層剥離剤 | |
JP2006151818A (ja) | 皮膚化粧料 | |
JP2007031316A (ja) | 抗変異原性を利用した抗紫外線刺激剤 | |
JP4246150B2 (ja) | 皮膚化粧料組成物 | |
EP0640581A1 (en) | Endermic nutrient material and cosmetic composition containing the same | |
JPH1179937A (ja) | ニキビ改善用皮膚外用剤 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
GD4A | Issue of patent certificate for granted invention patent | ||
MM4A | Annulment or lapse of patent due to non-payment of fees |